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Background and aim: General practitioners (GPs) who possess a high level of 
knowledge about chronic obstructive pulmonary disease (COPD) and good skills 
in managing COPD, other chronic conditions, and multimorbidity are prerequisites 
for optimal COPD care. However, there is a substantial discrepancy between COPD 
guidelines and practice. The general aims of this doctoral project were to describe 
the problem of underdiagnosis of COPD in Swedish primary care, explain reasons 
for underdiagnosis and deprioritization of COPD from a GP’s point of view, and 
investigate whether continuing medical education (CME) can improve GPs’ level of 
knowledge about and skills in managing COPD.  
Material and methods:  This mixed method implementation research project 
included four papers derived from three studies conducted in Stockholm County 
primary care. Study 1 (Paper I) was a quantitative, descriptive, epidemiological, 
targeted case-finding study. It used medical records and spirometry results from 
138 patients diagnosed with respiratory tract infections in urgent primary care to 
determine the prevalence of undiagnosed COPD and factors associated with it. 
Study 2 (Paper II) was a qualitative study using grounded theory methods. It ex-
plored obstacles to bringing up COPD at patient-doctor consultations. Data were 
collected via focus group and individual interviews with 59 GPs. Study 3 resulted 
in two papers. Paper III presented the study protocol for the PRIMAIR study, a 
three-armed cluster-randomized controlled trial with two levels of outcomes 
(physicians, patients). Paper IV described the GP results of PRIMAIR. Twenty-four 
PHCCs were randomized into two CME intervention arms: case method learning 
(CM) (n=12) and traditional lectures (TL) (n=12). A reference group without CME 
(n=11) was recruited separately. GPs (n=255) participated in the study arm to 
which their PHCC was allocated: CM, n=87; TL, n=93; and reference, n=75. Two 
2-hour CME sessions were given in a period of 3 months. GPs’ pre- and post-CME 
levels of knowledge were measured with a 13-item questionnaire (0-2 points per 
question, total maximum score 26 points).
Results: In Study 1, the prevalence of previously undiagnosed COPD in the 138 pa-
tients was 27% (95% CI ±7%); 44.7% were in stage 1 (mild, FEV1≥80% of predict-
ed), 52.6% in stage 2, (moderate, 50%≤FEV1<80% of predicted), 2.6% in stage 3 
(severe, 30%≤FEV1<50% of predicted), and 0% in stage 4 (very severe, FEV1 <30% 
of predicted). We observed a significant association between COPD and being 
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≥55 years (OR = 10.9 [95% CI 3.8-30.1]) and between COPD and smoking intensi-
ty (>20 pack years) (OR = 3.2 [95% CI 1.2-8.5]). Sex, current smoking status, and 
type of infection were not significantly associated with COPD. Study 2 revealed 
that time-pressured patient-doctor consultations led to deprioritization of COPD. 
During unscheduled visits, deprioritization resulted from focusing only on acute 
health concerns, whereas during routine care visits, COPD was deprioritized in 
multimorbid patients. GPs’ reasons for deprioritizing COPD were: not becoming 
aware of COPD, not becoming concerned due to clinical features, insufficient local 
routines for COPD care, negative personal attitudes and views about COPD, man-
aging diagnoses one at a time, and perceiving patient motivation as low. The study 
3 protocol article (Paper III), presented in-depth information about disease knowl-
edge (COPD), CME and pedagogical research, cluster statistics, and the plans for 
implementing PRIMAIR. In the paper on PRIMAIR’s GP outcomes (Paper IV), 133 
GPs (52%) completed the questionnaire both at baseline and 12 months. Both 
pedagogical methods resulted in small yet significantly higher total questionnaire 
scores in level of COPD knowledge at 12 months: CM, 10.34 (baseline) vs. 11.44 
(12 months); TL, 10.21 vs. 10.91 (p<0.05). There were few significant differences 
between the two CME methods. Both intervention arms had significantly better 
results than the reference group. At both baseline and 12 months, all three groups 
(CM, TL, reference group) had relatively high scores on questions about smoking 
cessation support and low scores on those that measured spirometry interpreta-
tion skills, interprofessional care, and management of multimorbidity. 
Conclusion: It is crucial for GPs to identify patients at high risk of COPD and offer 
them spirometry testing to detect COPD early, as it may help motivate patients to 
quit smoking. To reduce the risk of deprioritizing COPD in patient-doctor consulta-
tions, we suggest that GPs actively apply a holistic consultation approach and that 
policy makers and PHCCs offer extended consultation time for multimorbid pa-
tients. It is difficult to improve the generally low levels of knowledge about COPD in 
GPs, at least via short CME sessions. For GPs, CME is career-long, cumulative expe-
rience, which makes it challenging to evaluate single CME interventions. More time 
for GPs’ work and professional development regarding management of patients 
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Like most high school kids, I struggled to decide what I would become when I grew 
up. I liked going to school, so I thought working as a teacher would be nice. Or 
maybe a historian. Or a journalist. Or a physiotherapist. My friends and teachers 
thought I would make a good doctor. My parents just wanted me to decide. 
Eventually, my parents were able to relax. My high school friends and 
teachers’ prophecy that I would study medicine proved to be right, and I moved to 
Stockholm to go to school at Karolinska Institutet. One of my teachers at medical 
school in the early 1990s was a senior pulmonologist, who was (and still is) an 
expert in COPD. As a young student, I was impressed by the way she used sim-
ple, basic clinical skills to examine patients and by the respectful and kind way 
she treated people. She had this energizing aura about her. Once, in passing, she 
praised me for my undoubtedly fumbling attempts to examine and converse with 
a patient on the ward. I was flattered and I soon understood that I, too, wanted to 
become a truly skilled physician. I realized that I needed to learn what my teacher 
already knew: how to approach my patients so that I would understand their situ-
ation better. I then decided to become a GP. However, my teacher had managed to 
plant two more thoughts in my mind: an interest in airway diseases and a reawak-
ened desire to share what I know by teaching others. 
Many primary care patients come to see their GPs for airway problems. 
This gives GPs wonderful opportunities to learn and explore more about respira-
tory diseases in the general public. My growing curiosity about GPs’ roles in the 
management of airway diseases eventually spurred me to start researching the 
topic. I signed up for a course in research methodology at the Centre for Family 
Medicine (CeFAM), now the Academic Primary Health Care Centre (APC). Later, Ce-
FAM helped me put together a research team and take my first steps as a doctoral 
student. I was also employed part-time as a care development leader at CeFAM, 
which involved working with continuing medical education (CME) in primary care. 
Somehow, my high school plan of becoming a teacher had materialized. I started 
to look at CME with new, researcher’s eyes. Soon, my doctoral project came to 
include a study about CME.
I am thankful for the opportunities I have been given and the choices I 
have made. During my 20 years as a GP, I have been fascinated by my profession: 
the versatility that paves the way for holistic, salutogenic, humanistic—and yet 
realistic—views of patients. I have seen people leave my room happy, strength-
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ened, relieved, and hopeful, but also distressed and worried. I have had all those 
feelings myself. The job does not leave anyone unmoved. Becoming someone’s GP 
takes years, and I am still learning. 
The years that I have worked with CME have made me respect, appreciate, 
and value my GP colleagues. All the creative discussions, unexpected realizations, 
and some good laughs that have taken place during collegial dialogues and other 
CME sessions have helped me develop professionally and given me strength to 
cope with today’s tough primary health care environment. As a CME teacher, I have 
also had the privilege of experiencing moments of “the ultimate teacher’s high”: 
the feeling that you have made others understand new things so they change their 
behavior.
Doctoral studies have not only taught me to think critically (and manage a 
bit of statistics), but also to organize, plan, and execute projects. I have grown as 
a physician, a teacher, and a person. I look forward to continuing all three of my 
professional roles as researcher, educator, and GP. After all, doctors can’t wear 
their degrees around their necks. That’s what stethoscopes are for.

2120 1.  BACKGROUND
1.1  FAMILY MEDICINE AND GENERAL PRACTITIONERS IN A CHANGING  
  HEALTH CARE SYSTEM IN SWEDEN
Family medicine, also called general medicine, is the medical specialty of primary 
care. General practitioners (GPs) in Sweden are physicians with a specialist degree 
in family medicine. They are the backbone of the quality of primary health care. 
The following description of the development of family medicine and primary care 
in Sweden, found in the chapters 1.1.1 to 1.1.3, is mainly based on the 2016 report 
“Effective care,” by Göran Stiernstedt et al. The report aimed to find the most ef-
fective way to use financial and professional resources in Swedish healthcare [2].
1.1.1 Historical perspective
Until World War II, GPs in Sweden played a central role in providing public health 
care. Hospitals with urgent care units became more common in the 1950s. In Swe-
den, the number of GPs began to decline and the number of hospital-based physi-
cians started to increase. Uncertainties about the role and the level of competence 
of GPs appeared, young physicians were drawn to the hospitals, and recruiting new 
GPs became more difficult. Indeed, GPs experienced a degradation of their position 
as experts in medical care, which lasted over two decades. The situation began to 
change in the 1970s as Swedish politicians realized the benefits of organized public 
health care delivered by GPs. The organizational idea and term “primary health 
care” appeared [3], primary health care centers (PHCCs) were established around 
the country, teamwork with district nurses became GPs’ standard working method, 
and reimbursement systems were reformed to benefit the newly started PHCCs. 
Simultaneously, the term “family medicine” came into being to describe GPs’ pro-
fessional specialty, and medical residency for GPs was standardized. 
  However, there was still no clear description of which professionals in the 
chain of health care were ultimately responsible for which activities. Thus, some-
what paradoxically, referrals from secondary to primary care started to increase 
in the 1970s. Before long, PHCCs were providing health care to new patients with 
more complicated diseases than before and were asked to conduct more medical 
investigations before referring a patient to secondary care. At the same time, the 
number of GPs did not grow, laying the foundations for the heavy workloads that 
still characterize GPs’ work [4].
“General practitioners are physicians who focus on the people who have  
diseases, not just the diseases that they have.” (Lee, TH. 2008 [1])
1.1.2 The organization of primary care in Sweden today 
Today, Swedish primary care is a mix of two models described in a 2003 Canadian 
analysis of primary care organizations in OECD countries [5]. The first is an “inte-
grated community model,” in which PHCCs are responsible for meeting the needs 
of a geographically defined population and for integrating their work with that 
of other health care providers to achieve this goal. The second is a “professional 
coordination model,” in which PHCCs provide medical services to those who seek 
or choose to register to obtain them. At a typical Swedish PHCC today, several GPs 
work together and in close cooperation with other professionals, such as nurses, 
physiotherapists, occupational therapists, and counsellors. An average PHCC in 
Sweden is responsible for approximately 10,000 registered patients. Practically 
all GPs are employed by PHCCs, which are run by county councils, either directly or 
through contracts with private companies. PHCCs often have specialized, nurse-
led clinics to address prevalent diseases, such as diabetes, heart failure, and 
asthma/COPD [6]. 
  The patients who visit GPs today vary from “occasional seekers” (patients 
without chronic conditions who seek medical help) to “regulars” (patients who 
often have chronic or multiple health issues). Unless the patient seeks urgent care 
for a single health problem, Swedish GPs usually address multiple health issues 
during one consultation, which can take up to 20 to 30 minutes. Ideally, patients 
have their own family doctor, a GP they consult whenever they have health prob-
lems. GPs consider patient continuity an essential characteristic of primary care. 
There is a positive association between patient-doctor continuity in primary care 
and outcomes such as patient satisfaction, adherence to treatments, fewer hospi-
talizations, better health status, and lower costs [7, 8]. However, in reality, discon-
tinuity in the patient-doctor relationship is common, especially for urgent care 
visits and “occasional seekers.” 
1.1.3 The state of family medicine today
From the mid-1980s to the present, the burden borne by primary health care has 
continued to increase [9]. The rules for many of the structural changes that have 
affected the interactions between and responsibilities of primary and secondary 
care have primarily been set by policymakers and representatives of secondary 
care. No substantial redistribution of resources from secondary to primary care 
has materialized even though demanding tasks continue to be moved from sec-
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ondary to primary care. The aging of the population is also increasing the workload 
in primary care, as it means that more people experience severe chronic condi-
tions and multimorbidities.  Still, clear and coherent communication between 
primary and secondary care is often absent, as are clear chains of care. On a 
positive note, all parties presently agree that cooperation and clarity about shared 
responsibilities are urgently needed.  
  The changes in primary care in recent decades have not led to substan-
tial improvements in primary care. Many primary care patients are frustrated by 
discontinuity and lack of easy access to primary care. In parallel, many GPs feel 
stressed because the situation makes it so difficult to practice high quality family 
medicine. On a typical work day, GPs take care of a mix of urgent and regular 
patients, patient administration (including correspondence with patients and 
specialist care consultants by mail or telephone), supervision of junior colleagues 
and students, and management assignments. However, GPs may find it difficult 
to balance the different tasks. The reimbursement-related demand that GPs pack 
as many patient visits as possible into the working day contributes to stress, as 
it does not always harmonize with GPs’ pursuit of patient continuity and a fami-
ly-centered approach. Additionally, the versatility of the work, limits to knowledge 
in specialized areas of medicine, and uncertainty in decision-making may lead to 
increased stress [10]. 
  A 2015 survey of approximately 4000 Swedish GPs revealed high levels 
of stress due to heavy workloads [11]. In the strained work environment, GPs and 
their managers tended to deprioritize time for professional development and 
continuing medical education (CME). Physicians in Sweden do not have to par-
ticipate in CME is to keep their licenses. The managers of PHCCs are ultimately 
obligated to make sure their personnel are regularly provided with the necessary 
CME. Nevertheless, GPs in Sweden report they have, on average, less than 60 
minutes per week for professional development, including unplanned collegial 
discussions, and one of six GPs report they have no time at all for CME [12]. About 
half of the GPs in Sweden today have seriously considered leaving the profession 
because of the high stress levels and unsatisfactory working conditions [11]. Thus, 
the current situation can be described as an ongoing crisis in family medicine. 
Similar alarming signals are found in other Western countries today. In the United 
Kingdom, studies show that the substantial increase in the levels of stress and 
distress in GPs are associated with significant increases in patients’ care-seeking 
behavior and with total clinical workload. The studies suggest that primary care in 
the United Kingdom, as currently delivered, is now close to reaching its saturation 
point [13, 14].
1.2  CHRONIC OBSTRUCTIVE PULMONARY DISEASE – A COMPLEX AND 
  MULTI FACETED CONDITION  
The organizational changes in recent decades mean that management of chronic 
conditions and severe multimorbidities has become a central part of GPs’ work. 
Chronic obstructive pulmonary disease (COPD) is an example of such a disease. 
Moreover, it is both diagnosed and almost entirely managed in primary care in 
Sweden [15]. 
1.2.1 Epidemiology and costs of COPD
COPD is a common cause of morbidity worldwide; prevalence and mortality rates 
due to COPD continue to rise [16]. Today, COPD is the fourth most common cause 
of death in the world, after heart attack, stroke, and lower respiratory infections 
[17]. Despite some improvements in recent years, at least in the Western world, it 
is still grossly underdiagnosed and insufficiently managed [15, 18]. COPD is largely 
a man-made illness. In high-income countries, it is mainly caused by active or 
passive tobacco smoking, whereas in lower-income countries, outdoor pollution, 
unventilated indoor environments (e.g., in which people are exposed to smoke 
from cooking fires), and tobacco smoking are the main inducers of the disease. 
Patients with asthma are at particular risk of developing COPD. In patients with 
asthma, smoking and insufficient treatment of asthma accelerate development of 
COPD. A patient who presents with features of both asthma and COPD has asth-
ma-COPD overlap syndrome (ACO). Patients with ACO  have worse lung function 
and more symptoms than those with asthma or COPD only [19].
  An estimated 7% of the general population of Sweden have COPD. Inter-
nationally, the prevalence is 3% to 12% overall [20-22], 9% to 10% in adults older 
than 40 years [23]. It is 25% to 50% in a general smoking population and increases 
with age [22, 24-26]. The prevalence of ACO in Sweden is approximately 3% [19].
  The majority of COPD expenses go to providing care for people in the most 
severe stages of the disease. The cost of COPD care in Sweden is approximately 
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1.5 billion euros (13.9 billion SEK) a year [27]. As COPD typically presents not only 
as an airway disease but also with multiple extra-pulmonary comorbidities, it has 
a significant and manifold impact on total public health care costs. Direct costs 
due to COPD are driven by hospitalizations, COPD-related comorbidities, and 
respiratory drugs. Indirect costs consists mainly of sick-leave expenses [28]. 
1.2.2 Pathophysiology and the classification of COPD stages
In COPD, chronic airway inflammation (bronchitis and bronchiolitis) and destruc-
tion of the lung parenchyma (emphysema) occur. Airway inflammation then seems 
to “spill over,” causing systemic inflammation that affects other organ systems 
(extra-pulmonary features) [29]. COPD should be suspected in any patient with 
dyspnea, chronic cough or sputum production, and/or a history of exposure to 
smoking or other risk factors. The diagnosis of COPD is based on typical patient 
history and chronic airflow limitation demonstrated with spirometry testing. Dis-
ease severity is assessed to guide therapy. Until 2011, the severity grade of COPD 
was determined only by airflow limitation (spirometry measures) in accordance 
with The Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria [30, 
31]. Between 2011 and 2017, the disease’s impact on patients’ symptom burden 
and the risk of future events (exacerbations, hospital admissions, or death) were 
added to the assessment of the severity grade, which gave rise to a new GOLD 
classification, A to D [31]. The current national guidelines in Sweden, published in 
2015, are based on the 2014 GOLD guidelines [32]. However, yet another update to 
the GOLD classification was made in 2017, in which the classification into groups 
A to D was based solely on the symptom burden and exacerbation history [33]. The 
2017 classification has not yet been implemented in Sweden. It involves changes 
in severity classification such that half of all patients with COPD would be classi-
fied in a lower risk-group than currently [34]. 
  
1.2.3 The slowly progressing symptoms of COPD 
The early stages of COPD are characterized by indistinct, sometimes even unno-
ticeable symptoms. The patient typically adapts to the mild symptoms and both 
the patient and health care professionals often fail to suspect COPD. The first 
noticeable symptoms and signs, such as hypertension, are often associated with 
organs other than the airway. In fact, when noticeable airway symptoms appear, 
and a diagnosis of COPD is made, it is common that a substantial part of predicted 
lung function has already been lost [35]. Fatigue, exertion dyspnea, increased pro-
duction of sputum, chronic cough, frequent respiratory tract infections (RTIs), and 
prolonged colds are typical early and noticeable features of the disease. As COPD 
advances, wheezing and chest tightness may occur. Eventually, comorbidities 
such as heart disease, depression, osteoporosis, gastroesophageal reflux dis-
ease, and myopathy emerge [15, 36, 37]. Later, acute deterioration characterized 
by increased dyspnea and sputum volume and purulence (i.e., exacerbations) start 
to occur [38, 39]. During an exacerbation, the patient experiences troublesome 
symptoms, which often require urgent medical care. However, some patients “ride 
out” their exacerbations at home: an estimated 40% to 50% of exacerbations are 
not reported to health care professionals [40-42]. Typically, the patient recov-
ers gradually from an acute exacerbation over the course of 7 to 8 weeks, slowly 
adapting to the symptoms that present in the post-exacerbation period. 
  Each exacerbation causes a permanent decline in lung function [43]. A 
significant proportion of patients who have started to exacerbate die within five 
years. In addition to poor lung function, older age and the presence of symptom-
atic comorbidities are closely associated with a higher risk of mortality [44, 45]. A 
permanent, slight worsening of lung function due to the exacerbation, which could 
be measured with spirometry, may go unnoticed because patients tend to adapt to 
their symptoms after each exacerbation, so warning signals may be missed [46]. 
“Nothing’s changed. Same old same old! And I’m quite happy with that.”  
(A patient with COPD, when asked how he was feeling a few weeks after an exacer-
bation,  Pinnock, et al. 2011 [46])
Under these circumstances, patients with COPD, their families, and their caregiv-
ers may be equally unprepared for a sudden, fatal deterioration (Figure 1) [46].
1.3  THE RATIONALE BEHIND THIS THESIS 
The roots of this thesis lie in primary health care’s commitment to managing the 
vast majority of patients with COPD. Thus far, primary health care has not been 
particularly successful in fulfilling this commitment, as clearly demonstrated by 
the gap between current guidelines and practice. Because GPs are usually the 
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Figure 1.   As COPD advances and relapses into exacerbations, a discrepancy arises between 
patients’ reported symptoms and their progressive deterioration over time. Adapted with permis-
sion from Figure 5 in Giacomini M, DeJean D, Simeonov D, et al. Experiences of living and dying 
with COPD: a systematic review and synthesis of the qualitative empirical literature. Ont Health 
Technol Assess Ser 2012;12:1–47 [47].
first health care professionals that patients with COPD encounter, GPs’ role in 
COPD care is essential to bridging the implementation gap. GPs’ competence in 
COPD care must be assessed, evaluated, improved via education, re-evaluated, 
and reassessed, and the outcomes need to be measured in both GPs and patients. 
1.3.1 COPD guidelines in primary care
Successful implementation of guidelines is the basis of patient-centered care and 
actions to prevent chronic diseases. In recent years, several largely compatible 
COPD guidelines have been published internationally, nationally, and locally. The 
guidelines referred to in this thesis were written by the Swedish National Board of 
Health and Welfare (2004, 2015), Swedish Medical Products Agency (2009, 2015),  
The GOLD (2014, 2017), and Stockholm County (the “Viss” clinical guidelines) [31, 
32, 48, 49]. 
1.3.2 The role of primary care and GPs in managing COPD 
Primary care is the first-line health care provider for the vast majority of people 
in Sweden and often the gate-keeper of secondary care. Thus, primary care is 
not only responsible for the early detection of many chronic diseases, but also 
has unique opportunities to do so and then provide patients with evidence-based 
treatments. The vast majority of patients with COPD are fully managed in primary 
care. Although the gap between the care called for in guidelines and that provided 
in practice has narrowed in recent years, there is still a clear discrepancy in both 
primary and secondary care [50]. In primary care, the discrepancy manifests as 
an insufficient detection rate, suboptimal treatment, and poor disease monitoring 
[15, 51-53]. More specifically, there is room for improvement in the early diagnosis 
of COPD, management of acute and maintenance treatments (such as choice of 
pharmacological therapies and use of inter-professional cooperation), and struc-
tured follow-up of patients at PHCCs [53-55].
  As COPD-related airway damage is irreversible, treatments aim to reduce 
symptoms and prevent exacerbations, thus improving quality of life and prognosis. 
The current guidelines rest on three pillars: 1) non-pharmacological treatment 
(smoking cessation, exercise, and nutrition), 2) pharmacological treatment, and 3) 
advanced treatment of severe stages (oxygen, surgical interventions, and palli-
ative care). Assessments of disease progress and therapeutic choices are made 
mainly by monitoring the development of symptoms. 
  Most patients need multidisciplinary management, in which interpro-
fessional cooperation is essential [56]. In Sweden, practically all PHCCs have a 
spirometer [15]. At a PHCC-based, certified asthma/COPD clinic, a specialist nurse 
works closely with GPs, is responsible for spirometry testing and patient educa-
tion, and coordinates the management of the patient’s COPD with pulmonary reha-
bilitation units, which are often organized and managed independently of PHCCs. 
1.3.3 The implementation gap
The International Primary Care Respiratory Group (IPCRG) has called for research 
on COPD guideline implementation [57]. Surveys have indicated that low familiar-
ity with current guidelines, difficulty interpreting spirometry results, time con-
straints, and therapeutic nihilism may lie behind poor implementation of COPD 
guidelines [58, 59]. Moreover, GPs often experience conflicts between current 
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guidelines and a patient’s individual needs or the GP’s autonomy [60, 61]. Obsta-
cles may also originate elsewhere in the healthcare system. Examples include 
financial disincentives and lack of access resources that are needed to implement 
guidelines, such as services, facilities, or equipment [62]. A 2014 study of GPs 
in southern Sweden suggested that patient safety; trust in the development of 
evidence-based, market-neutral guidelines; and sufficient time for dialogue with 
patients about the recommendations were the key motivating factors for good 
adherence to drug prescribing guidelines [60].
1.3.4 Using continuing medical education to reduce the implementation gap 
CME is commonly used to bridge the gap between theory and practice. In line 
with existing theories of adult learning, the American College of Chest Physicians 
recommends using multiple teaching techniques in CME. Case method learn-
ing, lectures, hands-on demonstrations, discussion groups, and role playing are 
examples of activities that can effectively change physicians’ knowledge and 
performance as well as clinical outcomes [63]. However, an Australian survey of 
2500 GPs found that GPs preferred lecture-based CME (a “quantitative” learning 
method) to interactive CME (a “qualitative” learning method) [64]. Moreover, it is 
obvious that when faced with a wide spectrum of CME choices, busy GPs need to 
compromise and prioritize. Consequently, much of the CME for GPs in Sweden is 
provided in short, 1 to 2 hour sessions, often in the afternoon, mainly in the form 
of semi-didactic lectures, and preferably in one-time educational meetings the 
PHCC. We were particularly interested in studying two types of CME methods.
- Traditional lectures (TL), which are mainly characterized by quantitative learn- 
 ing and carried out in didactic style with a CME leader who is an academic   
 expert. TLs often include short patient case vignettes that may or may not lead  
 to some interaction between the CME leader and the participants; i.e., they are  
 semi-didactic lectures. TLs primarily aim to reduce knowledge barriers at the  
 level of the individual participant.
 
- Case method learning (CM), which is mainly characterized by qualitative
learning but can be carried out in a similar setting and amount of time as TLs. 
Typically, CM does not involve didactic lecturing. The participants are active 
generators rather than passive recipients of knowledge. The teaching approach 
in CM is clearly interactive. At a CM seminar, one or two open-ended narratives 
(i.e., cases) are thoroughly discussed, and the CME leader acts as a facilita-
tor. The cases are always told from the perspective of a professional [65]. The 
primary aim of CM techniques is to improve clinical decision-making skills. Like 
other participatory learning methods, CM aims to improve participants’ level 
of knowledge by influencing their attitudes. CM requires maturity, as well as 
previous knowledge and clinical experience in the subject. When used in CME 
delivered in primary health care settings, CM can have a positive impact on 
learning [66, 67].    
Little previous research has investigated the effectiveness of CME methods for 
improving GPs’ knowledge about managing COPD. This disease is unique in that 
it is common, severe, and chronic; typically has significant comorbidities and 
psychosocial manifestations [68]; and is complicated by obstacles related to 
the patient, clinician, and care system [69]. As a CME educator at the Stockholm 
County Council, I was particularly in interested in learning whether the two-hour 
CME sessions that seemed so popular among GPs were a suitable way to teach 
and learn about COPD, as this topic had not been previously studied.  Addition-
ally, I wanted to investigate whether achieving knowledge at a qualitative (more 
advanced) level via CM would improve knowledge at a quantitative (less advanced) 
level that normally is achieved via methods such as TL.
  In this thesis project, I first set out to better understand the problem, 
asking the question, “What are some of the consequences of poor adherence 
to COPD guidelines in primary care?” I chose underdiagnosis as an example of a 
problem with adherence and studied it by investigating the rate of detection of 
previously unknown COPD in patients seeking urgent primary care. Next, I studied 
the reasons for the problem, asking “Why do GPs adhere poorly to the guidelines?” 
I addressed with a qualitative interview study. The final part of the project tested a 
CME intervention to address the question, “What can be done about the problem?”




The overall aim of this thesis was to explore GPs’ management of COPD and im-
prove their knowledge about COPD. There were three specific aims. 
1) To a) describe the prevalence and severity of undiagnosed COPD in patients  
 who were over 40 years, were current or former smokers, and presented with  
 respiratory infections at an urgent primary care unit and b) identify the varia- 
 bles in patients’ histories that were associated with previously unknown COPD.
2) To describe factors that hindered discussions between GPs and their patients  
 about COPD.
3) To evaluate and compare the effects of two common types of CME methods  





All investigations conform to the principles outlined in the 2017 Declaration of 
Helsinki [36]. The Regional Ethical Review Board in Stockholm, Sweden approved 
all the studies included in this thesis.
 The managers and participants at each of the PHCCs that actively contrib-
uted to the studies gave their written, informed consent to participate, with the 
exception of Study 1, in which written information about the study was provided 
and verbal consent obtained from the patients. Looking back, written consent 
would have provided the study group with a clearer record of consent to partici-
pate in the scientific project and would thus have been preferable.
 Spirometry testing (Paper I) involved a physical intervention, but as the 
tests were conducted by a trained person and in accordance with usual praxis, 
the research group judged that they were not risky for the patients. The patients 
whose spirometry results were abnormal were referred to their own GPs for fur-
ther action. The physicians who participated (Papers II and IV) were not exposed to 
any kind of physical intervention. It is possible that feeling peer pressure or feeling 
that one’s professional skills were being questioned influenced the focus group 
discussions, but the researchers did not considered this a major ethical prob-
lem. In the interview situations (Paper II) and the CME seminars (Paper IV), great 
effort was put into creating an open, tolerant and non-hierarchical atmosphere 
in the groups. Each session started with the CME leader clarifying the aims and 
intentions of the studies. Throughout the case method sessions, the CME lead-
er encouraged free, honest, and creative discussions. To further enhance open 
discussion, the managers of the PHCCs did not participate in group sessions. The 
participants were asked to treat the focus-group interviews as confidential and 
not talk about them outside the interview room. 
 In Study 3 (Paper IV), the recruitment of the reference group (11 PHCCs, 
75 GPs) deviated from an optimal design for cluster randomized controlled trials, 
as it was recruited separately from the two intervention arms. All the PHCCs that 
wanted to participate in the two intervention arms were primarily interested in 
signing up for CME in COPD, and were thus given it. However, because of lack of 
resources, we could not offer CME to the reference group after the study period, 
and the group was informed of this before they agreed to participate.  
 All data in paper format (spirometry slips, questionnaires, and written 
consent forms) were anonymized, coded, and kept in locked storage during the 
3.  ETHICAL CONSIDERATIONS
active research phase. They were later archived in accordance with Karolinska 
Institutet’s regulations. The spirometry results and questionnaire replies were 
anonymized, and together with the code keys, transferred to digital data files to 
which only the researchers had access. Data were presented at the group level, 




3938 4.  METHODOLOGY
The methods are described in detail in Papers I to IV and summarized in Table 1.
4.1  METHODS
4.1.1 Paper I: Epidemiological case-finding study in patients with respiratory  
  tract infections
The participants in this cross-sectional study had visited either Brandbergen 
primary health care center or an urgent primary care unit in Handen, both in the 
Southern suburbs of Stockholm, between January and March 2005. They were 
40 to 75 years old, either current or ex-smokers, did not have a known diagnosis 
of asthma or COPD, and had sought urgent primary care for the symptoms of an 
acute respiratory infection. 
  To determine the sample size needed, we chose a COPD prevalence of 30%. 
We based this decision on the result of previous studies that resembled ours in 
design [26, 73]. A random sample of 140 patients would have given a 95% confi-
dence interval (CI) of ±7%, which was estimated to be sufficient to meet the aims 
of the study. A consecutive sample of 250 patients with an ICD-10 diagnosis of a 
RTI was extracted from the medical records. A total of 190 patients met the inclu-
sion criteria and agreed to undergo spirometry testing 4 to 5 weeks after the RTI. 
However, 40 did not attend the spirometry appointment, so a total of 138 patients 
completed spirometry testing [74]. All the spirometry tests were carried out by HS 
and performed and interpreted on the basis of the GOLD criteria [38]. Informa-
tion about the participants’ smoking intensity (pack years), age, and gender was 
collected at the spirometry appointment. Patients who needed further medical 
attention, including all who were diagnosed with COPD, were referred to their GPs 
for follow-up. 
  The statistical analysis was performed using STATA, version 8 [75]. Summa-
ry statistics were computed using standard parametric methods. Multiple logistic 
regression was used to analyze variables associated with a COPD diagnosis, which 
also provided odds ratios and 95% CI. P-values of <0.05 were considered statisti-
cally significant.
Table 1.   Summary of the methods.
1 Standard Protocol Items: Recommendations for Interventional Trials 2013 explanation and elaboration: 
guidance for protocols of clinical trials [71].
2 Consolidated Standards of Reporting Trials 2010 statement: extension to cluster randomised trials [72].
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4.1.2 Paper II: Qualitative study about factors that hinder discussions about  
  COPD in patient-doctor consultations
Study 2 was a qualitative study. Data were collected via semi-structured individ-
ual and focus group interviews of GPs at 11 PHCCs in Stockholm County between 
2012 and 2014. The analysis was inspired by grounded theory methods (GMT), and 
a constructivist perspective as described by Kathy Charmaz was used [70, 76-78]. 
We performed constant parallel data collection and comparative analysis in which 
the process of collecting, coding, and analyzing data was undertaken at the same 
time as theoretical sampling to generate a theory that answered the research 
question. The process is illustrated in Figure 2.
  I carried out all the interviews, and in line with Charmaz’ perspective, 
sought to understand differences and variations among the participating GPs. Us-
ing these differences and variations, I attempted to co-construct meanings while 
remaining constantly aware of my relationships to the participants and pre-under-
standings that may have affected the procedure. As our research group consisted 
only of GPs, we consulted a non-GP researcher (IH) to help increase my awareness 
of my pre-understanding before each interview and achieve the best possible 
objectivity and open-mindedness in new interview situations.
Figure 2.   A figure showing the principal steps in the process of generating and developing a 


























4.1.2.1 Purpose-driven theoretical sampling
We started out by employing open sampling and soon proceeded to theoreti-
cal sampling. In other words, the sampling became theoretically oriented; i.e., it 
aimed to generate and develop a conceptual and explanatory theory to answer the 
research question. This purpose-driven approach is the major difference between 
GTM and simpler qualitative research methods, such as content analysis. The the-
oretical sampling was continually directed by the emerging theory. We followed up 
leads as they arose in the data, progressively focusing data collection to refine and 
integrate the theory [76]. Memo writing helped us organize the expanding data. 
  Example 1 illuminates how the constant parallel data collection and 
comparative analysis were performed by applying theoretical sampling at an early 
stage in the study:
Example 1. Theoretical sampling.
Initially, we used open sampling, conducting focus group interviews with all GPs at the two 
first PHCCs that agreed to participate in the study. The focus of these two interviews was to get 
answers to our original research question, “Why don’t GPs adhere to the current guidelines for 
COPD?” Based on the analysis of the initial two interviews, we discovered that COPD was rarely 
brought up during patient-doctor consultations. This made us wonder what factors lay behind 
not discussing COPD, so we backed up and asked a new, modified research question, “What are 
the factors that led to deprioritization of COPD in patient-doctor consultations?”
 We then proceeded to use theoretical sampling. We looked for GPs who could further 
explain or provided nuanced information relevant to the question. The first two interview groups 
had included a rather large number of young GPs, which affected what was discussed. For 
example, they brought up issues related to their phase of life and relative lack of professional 
experience: “I have just come back from parental leave and feel I am all out of practice when it 
comes to COPD!” To find older and more experienced GPs for the next interviews, we used our 
own network of acquaintances and snowballing (i.e., previous interviewees referred us to new 
GPs). The next interviews revealed new information, and the data thus became richer. Theoret-
ical sampling continued. Some GPs had described how COPD nurses’ routines made the GPs 
prone to bring up COPD with patients. We then wanted to interview GPs whose PHCC did not 
have a COPD nurse to see whether this would affect the ways the GPs prioritized the disease. In 
these next interviews, we also found new information that enriched the data.
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4.1.2.2  Interviews 
An initial interview guide was used but was constantly developed as the study 
proceeded. The initial interviews focused on gaining information about clinical 
situations that would lead GPs to suspect COPD in a patient. The open discussion 
led by HS encouraged the participants to share their opinions, points of view, and 
experiences with each other, which led to follow-up questions. 
  After gathering new information and insights, the research group assessed 
and condensed the information, which resulted in new, focused interview ques-
tions aimed at achieving deeper understanding. In this way, the interviews focused 
on successively more specific issues, such as the way COPD care was organized at 
the PHCCs, GPs’ personal views on smoking, and how shame and guilt in patients 
with COPD could affect the GPs. Concepts, subcategories, categories, and their 
interrelationships emerged, as did a core process. We continued the process until 
theoretical saturation was reached; i.e., until no new issues came up in the inter-
views and theorizing had come to a sufficiently comprehensive end. We presented 
a preliminary theory, which we verified in two more focus group discussions, after 
which we could write the final theory.
4.1.2.3  Analysis: steps and coding
The analysis was carried out in four steps that coincided with the phases of initial, 
focused, and theoretical coding (Figure 3). In initial coding, HS, AN, and SM worked 
in parallel to extract meaningful sentences from the entire text line-by-line or 
incident-by-incident. Those sentences became the first rudimentary categories. 
During this process, we constantly looked for concepts and patterns in the data 
and compared data across all the interviews. This analysis led us to focused cod-
ing, in which the data were condensed into the most important subcategories and 
categories. We constantly tried to determine whether newly emerged subcatego-
ries were important to the development of new categories or whether they were 
dimensions or properties of categories we had already identified. In other words, 
focused coding led us to structure the relationships among categories and sub-
categories. In theoretical coding, we crystallized the emerging core process into 
a theoretical model, finding answers to questions like “When?” “Where?” “How?” 
and “Why?” and using diagrams and flow charts to illustrate the process.  
Figure 3.   Schematic figure of the four steps and the different phases of coding in grounded the-
ory methods. The coding process is shown via examples of three paths (green, red, and blue) that 
led to the main categories. Sample raw data from the original interview transcriptions are only 
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4.1.3 Papers III and IV: Cluster randomized controlled trial about the effect of  
  continuing medical education (the PRIMAIR study); methods and GP  
  results
Paper III was a protocol article that described the methods of the PRIMAIR study in 
detail. The protocol article was included in this thesis because PRIMAIR was such 
a large project that required multiple kinds of research expertise to design and 
carry out and because I was deeply involved in each phase, from project design 
through implementation and analysis. The protocol was developed on the basis of 
1) an in-depth exploration of current CME literature, 2) current and former COPD 
guidelines, and 3) research about cluster randomized trials and relevant statistics 
that included consultation of literature and a statistical expert (SEJ). The original 
ideas and features of the interventions in PRIMAIR were based on clinical and 
educational experiences of members of the research group and our fellow GPs in 
clinical practice.
  Paper IV described the GP-related outcomes of PRIMAIR. It also presented 
the final statistical methods we chose to use and further information about the 
challenges of CME research. We have also published an article on the baseline 
data gathered about the GPs (the “related article” mentioned in the list of scientif-
ic papers at the beginning of this thesis) [79].
4.1.3.1  Summary of enrollment in PRIMAIR
We sent e-mail invitations to all 80 PHCCs in Stockholm with >10,000 registered 
patients. The first 24 PHCCs that agreed to participate were included. The refer-
ence group of 12 PHCCs was recruited separately. The flow chart of PRIMAIR as 
presented in Paper III is summarized in Figure 4.
  Paper III was written in line with Standard Protocol Items: Recommenda-
tions for Interventional Trials (SPIRIT) 2013 explanation and elaboration: guidance 
for protocols of clinical trials [71] and the Consolidated Standards of Reporting 
Trials (CONSORT) 2010 statement: extension to cluster randomised trials [72]. Paper 
IV also followed the CONSORT statement, and both papers included flow chart 
models required by these sources.
4.1.3.2  The PRIMAIR schedule
The research group (HS, AN, SM, BS, and IK) started working on PRIMAIR in 2013, 
planning, constructing, and testing the material for the educational interven-
tions and the assessment tools (questionnaires). PHCCs, GPs, and patients were 
recruited between January and August 2014, after which computerized cluster 
randomization was completed. The CME interventions were carried out from Sep-
tember 2014 to January 2016. GPs completed the questionnaire just prior to the 
start of the first CME session. Twelve months after baseline, the GPs who com-
pleted the study replied to the questionnaire a second time. The reference group 
(no CME) was recruited separately. Because of limited funding, we were unable to 
offer reference PHCCs CME after the study period. The reference GPs replied to 
the baseline questionnaires between November 2015 and May 2016. They were 
thus the last participants from whom 12-month follow-up data were collected (in 
May 2017). Patient recruitment and collection of patient data occurred parallel to 
the collection of data from the GPs. Patient data were collected by HS between 
2014 and 2017.
Figure 4.   Flow chart of PRIMAIR adapted from Figure 1 in Paper III. 
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4.1.3.3  CME interventions
Two kinds of CME were used, case method learning (CM) and traditional lectures 
(TL). The methods were compared with each other and to no CME (the reference 
condition). Both CME methods were provided in 2x2-hour educational meetings at 
each PHCC. HS led all 24 CM sessions, and four other lecturers led a total of 24 TL 
sessions. 
  PRIMAIR used outcome-based CME that followed John Biggs’ educational 
theory of constructive alignment [80]. Thus, intended learning outcomes, teach-
ing and learning activities, assessments, and the examination (GP questionnaire) 
worked together (were aligned) to enable learners to achieve deeper levels of 
knowledge. Biggs’ Structure of Observed Learning Outcomes (SOLO) taxonomy 
[81] helped us understand the level of learning required to achieve each intended 
learning outcome (Table 2). This, in turn, helped us choose teaching and learn-
ing activities, assessments, and examination questions on the GP questionnaire 
that were appropriate to and would facilitate each outcome. We thus chose TL as 
a learning method appropriate to achieving SOLO levels 1 to 3 (characterized by 
quantitative learning), and CM as a method appropriate to achieving SOLO levels 1 
to 5 (characterized by qualitative learning). 
4.1.3.4  CME sessions using case method learning 
Achieving the learning outcomes of the case seminars largely depended on the 
participants’ levels of activity and the facilitator’s ability to encourage discussion 
in an open, respectful, and creative educational setting [65]. At each CM session, 5 
to 15 GPs from the same PHCC met to read and discuss one case in groups of two 
and in the whole group. The cases were based on HS’s interviews with GPs. They 
were written in a narrative form by HS so that all the intended learning outcomes 
of the CME could be covered in the discussions. The GP was the main character of 
the story. The cases thus resembled virtual “role plays”: the GPs could put them-
selves in the place of the decision maker as they reflected on and discussed the 
cases. The first case (“The super doctor”) focused on managing an acute exacer-
bation during a busy and stressed GP appointment. It incorporated elements of 
interprofessional cooperation in the emergency room, the GP’s negative attitude 
toward smokers, and GP’s rationale for planning a follow-up visit. The second case 
(“The ingrained smell of smoke”) was about describing the problems of delayed 
detection of COPD, spirometry interpretation, maintenance therapies, handling a 
Table 2.   The alignment of the intended learning outcomes of case method learning, traditional 
lectures, and the examination (GP questionnaire) with SOLO taxonomy levels. SOLO levels 1-3 
(S1= prestructural, S2 = unistructural, S3 = multistructural) are characterized by quantitative 
learning. Levels 4-5 (S4 = relational, S5= extended abstract) are characterized by qualitative 
learning and involve gradually increasing demands on reflection, hypothesizing, creativity, dis-
cussion, and abstraction so that the learners can apply the new skills to new and broader areas.
Intended learning outcomes 
Acquire unstructured information about COPD 
pathophysiology, epidemiology, symptoms, treat-
ment principles, and prognosis.  
Identify suspected COPD patients, recognize initial 
investigations needed for diagnosis, and interpret 
spirometric results.
List treatments available, describe management of 
acute exacerbation of COPD and stable COPD, and 
list COPD co-morbidities. Recognize the responsi-
bilities of primary, secondary, and interprofessional 
care in COPD management.
Describe, discuss, analyze, explain, argue about, 
and compare knowledge about the management of 
COPD in a primary care setting, including man-
agement of an urgent visit characterized by time 
pressure and stress. Reflect over and pay attention 
to one’s own and others’ attitudes and judgments 
about COPD and smoking and how they may affect 
the prioritization of COPD in patients with comor-
bidities. Reflect over the mission and responsibility 
of primary care in COPD care. Describe physicians 
and nurses’ areas of responsibility in COPD care. 
Recognize where to find guidelines and further 
information.
Reflect on and combine new knowledge with own 
experiences to solve complex issues of COPD care 
for each patient in real-life situations by managing 
time constraints and aligning doctors and patients’ 
agendas so that active COPD care can be achieved. 
1SOLO = Structure of Observed Learning Outcome
SOLO1 level





















patient who lacked motivation to stop smoking, interprofessional cooperation, and 
managing the progressive advancement of COPD and its comorbidities. Thus, both 
cases were meant to illustrate typical primary care situations in which GPs need 
to successfully manage several tasks at once—like simultaneously playing sever-
al games of chess and being expected to win all of them. Shortened versions of the 
two cases are summarized in Examples 2 and 3; the full texts are found in Paper 
III. The questions that emerged during the CM discussions typically had no obvious 
right or wrong answers. Instead, they could be answered in several acceptable 
ways. The CM leader facilitated the sessions by asking the participants to discuss 
the context, contents, and ethics of the case and the responsibilities and tasks 
of the characters (i.e., who should perform the actions and how and when should 
they be performed). The leader then encouraged the participants to try to solve 
problems through detailed discussions, reflection, and collaboration on based on 
the knowledge, skills, and experience they already had. CM stimulated creative 
thinking, communication, tolerance of different views, the ability to defend one’s 
own point of view with logic and analysis, and decision making [82]. The teaching 
and learning activities at CM sessions were designed to help learners achieve 
SOLO levels 1 to 5 (mainly qualitative learning).
Example 2.  A shortened version of case 1, “The super doctor”
GP Karin Adamsson had recently returned from maternity leave and was excited to get back to 
work. It was a sunny day in October, and she was scheduled to be on duty as emergency doctor 
at her health care center that morning. Emergency shifts were understandably stressful, but 
today was a good day. There were always fewer patients in the middle of the week: the lull before 
the weekend storm. . . . Karin’s day started off as expected, and the first three patients came 
and went.  She had just received her fourth, when the emergency nurse, Maria, popped her head 
round the door. “Hey, Karin, would you be able to come down when you’re done with this patient? 
I’ve got someone with respiratory problems out there. It’s a regular. I need a prescription for the 
inhalations.” . . . Karin found a middle-aged man sitting alone in the emergency room with the 
door ajar. She briefly introduced herself to the ashen, slender figure sitting slightly hunched on 
the chair, smelling of smoke, arms hanging at his sides. “Kalle,” said the man. He was taciturn 
and short of breath, with an intense look in his eyes. Karin had never seen him before. “A regular, 
Maria said, she thought. “I suppose I’ll just have to get busy with the inhalation.” On the paper 
sheet on his stretcher, Maria had written in pen, “Lennart ‘Kalle’ Karlberg, 490612-xxxx, O2sat 
89%, PEF 200, B/P 150/90, P 90, temp 36.8.” Karin listened to Kalle’s lungs and established that 
his condition was obstructive. She called in Maria, who started administering the prescribed in-
halations. . . . Back in her office, Karin had a quick look at Kalle’s medical records. “It doesn’t say 
that he was a smoker, but you could tell by the smell,” thought Karin. . . . Twenty minutes later, 
Maria reappeared at her door while Karin was busy with another patient. “He’s done,” said Maria 
quickly and rushed out again. . . . Kalle was breathing more easily now. His lungs sounded much 
clearer; his saturation had climbed to 95% and his PEF to 220. He was a little more talkative now 
and his gaze less intense. He gave a little smile and told Karin he suspected he had gotten the 
cold from his grandkids. “. . . So I like to come here to breathe in a little medicine now and then. 
Figured I’d come tomorrow too. I normally do that. Damn good stuff this medicine. Smoked? Hell, 
yeah, for at least 50 years! But not these days, no way.” . . . Karin was not really convinced that 
it was worth the trouble to talk with Kalle about quitting smoking: he seemed to have a dubious 
lifestyle, and given that his COPD was self-inflicted, he should seek help for it himself. Besides, 
there were five patients still in the waiting room, all of them coughing and sniffling. . . . “Got to 
keep up the pace. Emergencies are emergencies, that’s my concern for today.” Karin prescribed 
a 5-day course of cortisone and antibiotics, renewed Kalle’s prescription for Bricanyl, and said 
to him, “Come back if you don’t feel any better.”
[Group discussion]
Example 3.  A shortened version of case 2, “The ingrained smell of smoke”
2007: Lars Holmgren was a resident GP at a medium-sized primary health care center in a small 
town on the coast, 10 miles or so away from the local hospital. He had lived with his wife and two 
children in this town his entire adult life. Lars was in his 30s, active in sports, and known locally 
as a skilled, cheerful, and pleasant doctor. He was involved in his children’s sports, and since he 
was interested in lifestyle issues, he also worked with an anti-smoking campaign for teenagers. 
He was a non-smoker and always had been. . . . One day in November, stepping into the waiting 
room, he spotted a familiar face: Gerd Alvén, a cashier at the local supermarket. A few years 
back, he had taken care of Gerd’s husband, who had COPD and had died recently. Lars ushered 
Gerd into his office, and as she waddled into the room, she was pursued by the familiar rank 
smell of stale tobacco. . . . “I’ve got such a pain in my back. I’ve had it for ages, but now it’s so bad 
I can’t sleep at night, can’t get myself into a good position. And my legs are acting up too, it’s the 
knee you know, it gives me grief when I walk. Ugh, I just feel so old and tired.” . . . Lars knew Gerd 
was a smoker too, and thought she probably had COPD as well. He had noticed that she was 
slightly out of breath when she came in with Gösta. . . . And then suddenly she said, “And then 
there’s this blasted cough of mine, too.” 
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[Group discussion]
. . . . “No, I’ve not had a cold particularly. It’s just this cough, and the back. I find it hard to sleep 
at times. I haven’t had a proper night’s sleep since—since—my husband passed away. I feel 
so lonely. I miss him so much. I don’t really know what to do with myself when I get home from 
work.” . . . Lars eventually established that neither her back nor her knee showed any sign of 
disease or injury. When he suggested a spirometric examination, she willingly agreed, but clearly 
became anxious and nervy. She understood, of course, that she might also be diagnosed with 
this fatal disease. But she wanted to do as the doctor suggested. 
[Group discussion]
. . . . A few weeks later, Lars saw her spirometry results: FEV1/FVC 0.40 and FEV1 at 48% of 
expected value. . . . Lars informed Gerd that she had COPD. He prescribed medicine for her and 
advised her to quit smoking. “I tried quitting before, but it didn’t work. I can’t give up. And I don’t 
want to, either.” . . . . Lars managed to make Gerd see Eva, a skilled asthma/COPD nurse. Gerd 
was clearly not motivated to quit smoking, so she and Eva agreed that Gerd would get in touch if 
she ever changed her mind. 
[Group discussions and practice of spirometry interpretation]
2010. Lars had recently become a registered GP, and despite the considerable increase in his 
workload, still enjoyed his job. Gerd was becoming a regular at the clinic’s new drop-in center. He 
had also received a few follow-up referrals from the hospital, where Gerd had sought emergen-
cy help for respiratory problems. On her follow-up visits to Lars, she usually said that she felt 
“no different” and wanted no more help. . . . After a hospitalization due to pneumonia and heart 
failure, Gerd’s condition worsened and she had to stop working. . . . Gerd was now ready to meet 
Eva again, but still found it hard to talk about smoking, although she did consent to let Eva help 
her with several things: Eva sorted out all the different medicines that Gerd had had over the 
years and suggested that she should use a walker. “It’s the best thing that’s ever happened to 
me!” exclaimed Gerd.
[Group discussion]
Epilogue to be read aloud by the educator at the end of the session: Gerd started to feel 
that she needed to see Eva and Lars more and more often as her exacerbations grew gradually 
worse. She became increasingly short of breath and started to lose weight. . . . Lars updated her 
medication, and Gerd still showed no interest in a quit-smoking program or physiotherapy. She 
occasionally ended up in the hospital again but did not like it there and was mainly managed by 
Lars and Eva. . . . Usually her oxygen saturation was at 91% to 92%—a little lower during exac-
erbations. Her COPD had advanced to stage 4. She was constantly short of breath: she found 
it hard to laugh, to cry, and even to eat. Since she was a smoker, she could not be given oxygen 
at home despite her respiratory failure. . . . Gerd remained anxious and tired and eventually 
refused to socialize. She was prescribed an SSRI but mainly found support in Lars and Eva. Their 
conversations often turned to the subjects of death and helplessness. . . . At the age of 72, six 
years after her diagnosis, she was ravaged by COPD. One day she did not wake up. She had died 
at home, alone. “Poor Gerd. If only she’d stopped smoking. If only we could have made her quit.” 
Lars wondered privately if there was anything he could have done differently.
[Final group discussion]
4.1.3.5 CME sessions in the form of traditional lectures
Achieving the intended learning outcomes following TL depended on TL leaders’ 
ability to convey the information needed to achieve the outcomes, but perhaps 
most of all on participants’ active learning efforts [83]. TLs were delivered in a 
traditional, didactic style. The TL leader acted as an academic expert; i.e., he or 
she decided on the content of the session and taught with predominantly one-
way communication, using PowerPoint presentations as a pedagogical tool. Some 
interaction between the leader and the students could occur; for example, when the 
leader answered questions. The teaching and learning activities at TL sessions were 
designed to help learners achieve SOLO levels 1 to 3 (mainly quantitative learning).
4.1.3.6 Data on GPs’ level of knowledge and other data collected in the study
We used the GP questionnaire to assess GPs’ level of knowledge about COPD. (For 
the full questionnaire, see Papers III and IV.) It was constructed by the research 
group, pretested in a “think-aloud” discussion with a group of non-participating 
GPs, and improved on the basis of the GPs’ feedback during that discussion. The 
13 questions were aligned with intended learning outcomes at SOLO levels 1 to 
3, which were included in both the CM and TL arms of the CME intervention. The 
questions were about “knowledge/skills” and “practical management” and con-
sisted of a mixture of multiple choice and open questions based on five short case 
vignettes. The responses to the open questions were analyzed using quantitative 
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content analysis. Responses were scored with a premade scoring template (see 
Paper IV for the full template), and the participants could score 0, 1, or 2 points per 
question. The higher the scores, the higher the level of knowledge. Additionally, 
data about GPs’ gender, age, and years in the profession were collected at baseline, 
as was demographic information about the PHCCs’ catchment area.  
4.1.3.7 Cluster-adjusted statistics
Most statistical analyses presented in Paper IV, including the initial power calcu-
lation, were adjusted for clusters. We used an intracluster (intraclass) correlation 
coefficient (ICC) of 0.01, which we chose on the basis of the results of previous, 
similar studies [84-86], to calculate 80% power. In theory, when ICC = 1, all re-
sponses within a cluster are identical. An ICC value close to 0 implies that the 
within-cluster variance is much greater than the between-cluster variance, and 
when ICC = 0, it indicates that the responses within a cluster are uncorrelated. 
Usually, ICC is between 0.01 and 0.02 in human studies, especially in primary care 
[85]. In the analysis phase, we chose to use a transition model adjusted for cluster 
randomized data because of its simplicity: in a transition model, the outcome vari-
able at a previous time point was included as a fixed effect covariate. We wanted to 
publish the ICC values of our results, as they could eventually help future research-
ers estimate the ICC for similar populations.

5554 5.  MAIN RESULTS
5.1  PAPER I: UNDIAGNOSED COPD IN PATIENTS WITH RESPIRATORY TRACT  
  INFECTIONS 
5.1.1 The prevalence of COPD and characteristics of the patients
The prevalence of COPD in the 138 patients was 27% (95% CI ±7%). Of the patients 
with COPD, 44.7% were in GOLD [31] stage 1 (mild, FEV1≥80% of predicted), 52.6% 
in stage 2, (moderate, 50%≤FEV1<80% of predicted), 2.6% in stage 3 (severe, 
30%≤FEV1<50% of predicted), and 0% in stage 4 (very severe, FEV1 <30% of pre-
dicted). Table 3 summarizes the characteristics of the patients. Women with COPD 
were significantly younger than men with COPD in both groups (with or without 
COPD). 
Variables Total COPD No COPD
N (%) 138 38 (27) 100 (73)
Age
Years, mean (95% CI) 55 (54-57) 62 (59-64) 53 (51-55)
Age group 40-54 years n (%) 62 (45) 5 (13) 57 (57)
Age group 55-70 years n (%) 76 (55) 33 (87) 43 (43)
Smoking intensity
Pack years1, mean (95% CI) 24 (22-26) 32 (27-36) 21 (19-24)
Pack years, median (range) 20 (5-75) 31 (5-75) 20 (5-56)
Smoking status
Current smokers, n (%) 73 (52.9) 25 (65.8) 48 (48.0)
Former smokers, n (%) 65 (47.1) 13 (34.2) 52 (52.0)
Diagnosis
Upper respiratory infection, n (%) 57 41.3) 15 (39.5) 42 (42.0)
Lower respiratory infection, n (%) 79 (57.2) 23 (60.5) 56 (56.0)
Viral infection/influenza, n (%) 2 (1.5) 0 (0) 2 (2.0)
Sex
Female, n (%)  19 (50) 58 (58)
Male  19 (50) 42 (42)
Table 3.   Description of 138 patients with respiratory tract infections seeking urgent primary 
care. Numbers in total and divided into groups with or without COPD.
5.1.2  Associations between COPD and patient characteristics
After adjustment for all explanatory variables included in the study, multiple logis-
tic regression analysis that used COPD as a response variable revealed a statisti-
cally significant association between COPD and 1) being older than 55 years and 2) 
having smoked more than 20 pack years (Table 4). Current smoking, sex, and type 
of respiratory tract infection were not significantly associated with COPD.
5.1.3 How good was our model at predicting new cases of COPD?
We used the observations above to create a model for predicting COPD. “Age ≥55,” 
“pack years ≥20,” and “current smoker” were included as positive predictors of 
COPD. The sensitivity, specificity, and positive and negative predictive values of the 
model and their 95% confidence intervals are shown in Table 5.   
We also used the receiver/response operating characteristic (ROC) curve to assess 
the most optimal prediction model for variables associated with COPD (Figure 5) 
[87]. The area under the ROC curve was 0.83.
Sensitivity   44.7%  (95% CI 30-60%)
Specificity 89.0% (95% CI 81-94%)
Positive predictive value        60.7% (95% CI 42-76%)
Negative predictive value        80.9% (95% CI 73-87%)
Correctly classified                         76.8% 
Table 5.   Characteristics of the model.
Table 4.   The association between COPD and patient characteristics.
Characteristic OR (95% CI)
Age 56-75 10.9 (3.8;30.1)   
Pack years > 20 3.2 (1.2;8.5)
Current smoker 2.5 (0.9;6.6)
Upper respiratory tract infection 0.8 (0.3;2.0)
Female sex  0.9 (0.3;2.1)
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5.2  PAPER II: FACTORS THAT HINDER DISCUSSIONS ABOUT COPD AT A  
  CONSULTATION 
5.2.1 Participant characteristics
Between 2012 and 2014, we recruited 59 GPs from 11 PHCCs in Stockholm County. 
The characteristics of the GPs are shown in Table 6. The PHCCs were located in ur-
ban or suburban areas of Stockholm. The demographic and socioeconomic char-
acteristics of the PHCCs’ catchment areas varied, as did the number of patients 
listed at the PHCCs. Both PHCCs with and without a nurse-led asthma/COPD clinic 
were included. 
  Initially, HS conducted five focus group interviews; four to ten GPs partici-
pated in each interview. To conclude the data collection, HS carried out four addi-
Figure 5.   The standardized values describing the area under the receiver/response operating 
characteristic (ROC) curve show how well the model discriminated between those with and with-
out the disease (excellent = 0.90-1, good = 0.80-.0.90, fair = 0.70-0.80, poor = 0.60-0.70 and fail 
= 0.50-0.60). The closer the ROC curve is to the upper left corner, the higher the overall accuracy 
of the test.
Characteristic Number %
  Mean Median 
Gender, n=59 
 Men 30  51 
 Women 29  49  
Educational degree, n=59 
 Specialist in family medicine 40 68
 Not a specialist in family medicine 19 32 
Age, mean (SD) 45.5 (10.5)
Age, median (range) 44 (28-68)
n=54 (missing data n=5)
Years in profession, mean (SD) 14.0 (10.2)
Years in profession, median (range) 12.5 (1-39)
n=43 (missing data n=16)  
 1-5 years 10  22 
 6-10 years 8  18 
 11-20 years 14  31 
 21-30 years 7  16 
 > 31 years 5  11 
Working at PHCC with nurse-based 
asthma/COPD clinic, n=59 
 Yes 45  76 
 No 14  24
Table 6.   Characteristics of the GPs who participated in the interviews about discussing COPD in 
patient consultations (n=59). No comparable routine data were available for GPs in Stockholm at 
the time of the study.
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tional individual interviews, a focus group interview with seven participants, and a 
focus group interview with five participants. The average duration of the interviews 
was 37 minutes (range, 23 to 55 minutes).
5.2.2 Time constraints and patients’ other health concerns lead GPs to 
  deprioritize COPD
The 59 GPs from 11 PHCCs described two main types of patient visits in primary 
care (urgent and regular visits) that seemed to lay behind the feeling of constant 
time pressure. In turn, the feeling of time pressure was the starting point of the 
process described in the theoretical model (Example 4).
Example 4. 
“You have to keep up the pace. You don’t have time to think.”  
(Female GP, 53 years, about urgent visits).
”I always feel there are too many things going on! And new things keep coming. It’s sleeping 
problems and it’s something on the skin, and it’s the GP’s destiny! It’s classic! And then I feel like I 
need to push [COPD] aside, or forward in the future.”  
(Female GP, 40 years, about regular visits)
 
Thus, the GPs’ main concern was “the difficulty of prioritizing COPD in the limited 
time available.” That is, GPs prioritized either one urgent medical issue or one of 
many diagnoses in a patient with multimorbidity, thus neglecting detection and 
long-term management of COPD. Hence, the core process, “prioritization under time 
pressure,” leads to deprioritization of COPD. The theoretical model summarizing the 
“process of omission or deprioritization of COPD at a patient-doctor meeting” is 
shown in Figure 6. (The complete model is found in Paper II.) GPs who were unaware 
that the patient had a diagnosis of COPD could omit COPD from the consultation 
without ever considering bringing it up. The prioritization of COPD in the consul-
tation depended on the following factors (i.e., the main categories): the clinical 
picture, local support, personal views, consultation approach (managing diagnoses 
one at a time or using a holistic consultation approach), and patient motivation. 
In the interviews, GPs described factors, events, and finally, processes that led 
them to either prioritize or deprioritize COPD in consultations. In the model shown 
in Paper II and the accompanying model (Figure 6), we chose to focus on the neg-
ative pathway; that is, the pathway that leads to deprioritization of COPD. At the 
same time, however, there were factors, events, and finally, processes that led GPs 
to prioritize COPD in consultations.  Such processes included GPs becoming aware 
of COPD because of a clinical concern, having a local support system (e.g., rou-
Figure 6.   The theoretical model summarizing the process of omission or deprioritizing of COPD 
at a patient-doctor meeting.
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tines, flow charts, and nurse-led COPD clinics at the PHCC), having neutral views of 
smoking and of COPD as a chronic disease, using a holistic consultation approach, 
and perceiving that the patient was highly motivated to seek COPD care and adhere 
to treatment.
5.3  PAPERS III and IV: THE EFFECTS OF CONTINUING MEDICAL EDUCATION ON  
  GPs’ LEVEL OF KNOWLEDGE OF COPD AND COPD MANAGEMENT SKILLS
The CME interventions were carried out at 48 educational visits to the PHCCs (two 
visits to each PHCC). The 24 CM sessions were led by HS, and the 24 TL sessions by 
four other lecturers, all experienced GPs who were also experienced in leading CME 
on COPD. 
5.3.1 Description of the participants
At baseline, 207 GPs attended the CME sessions. In the CM arm, 87 of 100 GPs 
(87%) agreed to participate in the study, and in the TL arm, 93 of 107 GPs (87%) 
agreed to participate. The reference group consisted of 75 GPs. The majority (90%) 
of the 27 GPs who did not agree to participate worked at a PHCC without a nurse-
led asthma/COPD clinic (p<0.005). They did not differ from the participants in age, 
gender, number of years in profession, educational degree, the care need index (CNI) 
of the PHCC’s catchment area (the CNI measures social deprivation), or whether the 
PHCC where they worked was publically or privately owned.
  Of the 255 participants who responded to the questionnaire at baseline, 122 
(48%) did not respond again at 12 months (“non-responders”). The remaining 133 
GPs were the final participants (“responders”). The characteristics of the respond-
ers and non-responders are seen in Table 7. A significantly higher percentage of 
the non-responders than responders were employed at PHCCs in socially deprived 
areas of Stockholm. 
  A significantly higher percentage of GPs in the CM arm than in the TL arm or 
the reference group worked at a PHCC with a nurse-led asthma/COPD clinic (64% 
vs. 36%-38%). The means for gender, age, years in profession, and the CNI of the 
PHCC’s catchment area did not differ significantly between the GPs in the three 
groups, and the participants were generally representative of Swedish GPs with 
regard to these characteristics [88].
Table 7.   The main characteristics of the participants.
Main characteristics Baseline 12 months
Participants All Responders Non-responders 
n (%) 255 (100) 133 (52) 126 (48)
Number of participants per 7.5 (2-15) 4.3 (1-10)
PHCC, mean (range)
Gender,  n (%)
Women 149 (58) 81 (61) 68 (56)
Age, mean (range)  47 (27-69) 47 (27-68) 47 (27-69)
Degree in family medicine, n (%)
Specialist in family medicine 184 (72) 102 (77) 82 (67)
Training to be a specialist in
family medicine 71 (28) 31 (23) 40 (33)
Years worked in primary care, 
mean (range) 14 (0-41) 15 (0-37) 14 (0-41)
Asthma/COPD clinic at PHCC,  n (%)
Yes 114 (45) 70 (53) 51 (42)
Ownership of PHCC
Stockholm County Council 132 (52) 71 (53) 61 (50)
Private 123 (48) 62 (47) 61 (50)
CNI1 of PHCC’s location,  mean (SD) 2.17 (0.78) 2.03 (0.67) 2.32 (0.86)
 range 0.92-5.05 0.92-5.05 0.92-5.05 
1 CNI, Care Need Index; COPD, chronic obstructive pulmonary disease; PHCC, primary health care center. 
The CNI is based on sociodemographic factors, including percentage of older adults living alone, children 
under age 5, unemployed people, people with low educational status, single parents, high mobility, and 
foreign-born people. High CNI = high sociodemographic burden; mean CNI in Stockholm County = 2.49.
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Figure 7.   Changes in the total scores in each study arm over time. Total score minimum = 0 
points, maximum = 26 points.
5.3.2 Scores between and within the study arms, before and after the CME
5.3.2.1 Total scores
Both CM and TL resulted in small yet significantly higher total scores at 12 months 
than at baseline (Figure 7). There was no significant difference between these two 
methods, yet both were significantly better than no CME (reference group). 
  Scores were unrelated to whether there was a nurse-led asthma/COPD 
clinic at the PHCC. At baseline, the GPs who worked at PHCCs in the most socially 
deprived areas (CNI 2.29-5.05, 21% of all GPs) had lower total scores than the 
others (8.50 vs. 10.32, p=0.000), and the non-responders in the deprived areas 
scored lowest of all non-responders (7.98 vs. 9.71, p=0.007). At 12 months, the 
GPs who had worked 21 to 30 years had significantly lower total scores than the 
others (10.55 vs. 11.77, p=0.016). The responders’ total scores were not associated 
with the GPs’ age or gender or whether the PHCC was privately owned or run by the 
county council.  
5.3.2.2 Scores on individual questions
A comparison of the arms revealed that the TL arm had a statistically significantly 
higher OR than the reference group of “scoring 1 or 2 points” (i.e., the participants 
had a partly or fully sufficient level of knowledge) at 12 months on two of ques-
tions: the question about the follow-up of stable patients (question 9) and the 
question about multimorbidity in a patient with airway symptoms (question 13). 
Similarly, the TL arm had a higher OR than the CM arm with regard to smoking ces-
sation support for patients who were motivated to quit smoking (question 6). The 
CM arm’s ORs were not significantly higher than the TL arm’s or reference group’s 
ORs on any of the questions. 
  Studying the changes in the scores within each study arm revealed that 
weak areas of knowledge remained weak and strong areas remained strong both 
pre- and post-CME. All participants’ scored similarly on the individual questions 
at baseline. At 12 months, many scored similarly to how they scored at baseline 
(Figure 8). On three questions, however, there were significant differences between 
baseline and 12 months in the proportion of participants who scored “1 or 2 points” 
and who scored “0 points.” In the CM arm, the scores on question 2 (spirometry in-
terpretation) improved between baseline and 12 months. In the TL arm, the scores 
on question 9 (follow-up of patients with stable COPD) improved. In the reference 
group, scores on question 13 (multimorbidity in COPD patients with symptoms 
from airways and/or COPD comorbidities) were lower at 12 months than at baseli-
ne. Scores were generally high on questions about smoking cessation support and 
low on those that measured spirometry interpretation skills, interprofessional care, 
and management of multimorbidity.
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Figure 8.   Changes in the scores per question and study arm, over time, presented as percent 
of participants who scored 1 or 2 points. Each response was given a score of between 0 and 2 
points; the highest possible score was 2 points. On questions 2, 4, 7, 10, and 11, only two scores 
were possible: 0 or 2 points.
¹Questions: 1) diagnostic procedures, 2) spirometry interpretation, 3) smoking cessation (unmotivated 
patients), 4) treatment of acute exacerbation, 5) follow-up of acute exacerbation, 6) smoking cessation 
(motivated patients), 7) maintenance treatment of COPD (GOLD B patients), 8) heart failure medication for 
patients with COPD, 9) follow-up of patients with stable COPD, 10) interprofessional interventions,  
11) managing a suspected respiratory failure, 12) multimorbidity in COPD patients without obvious symp-
toms from airways or COPD comorbidities (an annual checkup), and 13) multimorbidity in COPD patients 
with symptoms from airways and/or COPD comorbidities (an annual checkup).

6766 6.  DISCUSSION
6.1  MAIN FINDINGS
This thesis provides information about GPs’ work with patients with COPD. It ex-
plores conditions that contribute to obstructing and facilitating optimal manage-
ment of COPD in primary care in Sweden. 
  First, I addressed the problem of underdiagnosis of COPD and the im-
portance of early detection, asking the question, “What is the problem?” Paper I 
revealed that the prevalence of previously undiagnosed COPD was high (27%) in 
the target population. It described how assessing three simple variables in mid-
dle-aged or older patients with any kind of acute RTI could be a useful and feasible 
way to quickly and efficiently shortlist patients who should be referred to spirom-
etry testing to confirm COPD. The three variables were age, smoking intensity (i.e., 
pack years), and current smoking status. 
  Next, I addressed the question, “Why is there a problem?” The study 
focused on GPs’ role as one of the most important actors in the guideline imple-
mentation process. The findings shed light on the process that occurs when GPs 
deprioritize COPD in patient-doctor consultations that take place under constant 
time pressure (Paper II). GPs meet patients with COPD mainly in two ways: at 
urgent visits and at regular visits. Both visit types are prone to lead to time pres-
sure during the consultation. In urgent visits, GPs often feel that they have to rush 
through consultations, focusing on the urgent treatment of airway problems. Thus, 
plans for further COPD care are omitted. At regular visits, the scenario is dominat-
ed by other factors, mainly because of the need to manage several health issues 
(multimorbidity) in a limited period of time. Time pressure leads to a process of 
deprioritization for which GPs give six reasons: “Not becoming aware of COPD,” “Not 
becoming concerned due to clinical features,” “Insufficient local routines for COPD 
care,” “Negative personal attitudes and views about COPD,” “Managing diagnoses 
one at a time,” and “Perceiving a patient’s motivation as low.” Paper II also provided 
interesting descriptions about the general conditions that GPs often work in and 
about the role and identity of GPs.
  Finally, I attempted to answer the question, “What can be done about 
the problem?” by conducting a CRCT about the effectiveness of short CME inter-
ventions for GPs (PRIMAIR) (Papers III-IV). My coauthors and I used the findings 
of studies 1 and 2 to develop the contents of the CME. That is, we incorporated 
real-life primary care problems (e.g., multimorbidity, time pressure, and heavy 
workloads) instead of focusing only on teaching the guidelines, as is often done 
in CMEs. Because previous reports, research, and studies 1 and 2 had given us 
reason to believe that GPs’ schedules were busy and CME was often deprioritized 
[12, 89], we decided to offer short afternoon CME sessions as educational meet-
ings at the workplace. This way we could feel fairly positive that GPs would sign up 
for our trial. The 2x2 hour CME sessions used interactive, participatory pedagogical 
methods (case method learning) and didactic methods (traditional lectures). Both 
led to equally modest yet significantly great improvements in the GPs’ the level of 
knowledge about optimal COPD care than no CME. The results indicated generally 
unchanged high levels of knowledge about smoking cessation support, as well as 
insufficient proficiency in spirometry interpretation and insufficient knowledge 
about interprofessional care and management of multimorbidity.
6.2  THE TIMING OF THE STUDIES 
Study 1 (Paper I) was carried out separately from and some years before studies 
2 and 3 (Papers II-IV). Study 1 should be regarded as an initial study that sparked 
my interest in continuing to research the topic. The organization of primary care in 
Stockholm County and COPD guidelines remained essentially the same during the 
study period.   
6.3  PAPER I: FINDING CASES OF COPD IN PATIENTS WITH RESPIRATORY   
  TRACT INFECTIONS 
6.3.1 Need for a method to detect COPD earlier, preferably with minimal extra  
  effort on the part of GPs
6.3.1.1 Organized screening of the public or targeted screening of smokers?
As early detection of COPD saves lives, reduces suffering, and limits expenditures 
[90-92], many researchers have studied different approaches to finding new cases 
at an early stage. Study 1 resulted in a detection rate (prevalence) similar to those 
found in previous studies of risk groups (middle-aged or older smokers) from 
different contexts who replied to symptom-based questionnaires or participated in 
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random screening with spirometry [26, 73, 93-95]. Although early detection is im-
portant, the 2016 U.S. Preventive Services Task Force Recommendation Statement 
recommends against screening for COPD in asymptomatic people and concludes 
that the benefits of smoking cessation far outweigh the benefits of screening for 
diseases caused by smoking [96, 97]. Health care professionals should thus focus 
on modifying risk factors, especially smoking, and identifying patients with chronic 
respiratory symptoms. Identifying patients at risk of COPD and then managing to test 
them using spirometry, however, is challenging [98]. The patients described in Paper 
I were highly motivated to undergo spirometry (75% of all invited patients attend-
ed), even though the tests took place several weeks after the urgent visit, and the 
patients had not previously met the researchers. The high attendance rate among 
the patients could have been a sign that they were worried about having COPD, 
possibly after having made their own conclusions about COPD and their smoking 
history. Previous research shows that patients at risk of COPD seem to be respon-
sive to information about COPD and realize the benefits of quitting smoking. New 
diagnosis of COPD are associated with increased rates of smoking cessation [99].
6.3.1.2 The more smokers in the population, the easier it is to screen for COPD 
The authors of a 2014 study argued against screening for COPD in smokers with 
RTIs, as their results indicated that few smokers actively seek health care for 
RTIs [100]. Moreover, the work of other researches also indicates that smokers 
avoid seeking health care [101, 102]. The 2014 authors thus suggested that rather 
than relying on patients seeking health care for respiratory symptoms, strategies 
for early detection of COPD should be directed toward the public [100]. However, 
general screenings of the public are questionable [96]. On the other hand, meth-
ods for targeted screenings should be further studied, keeping in mind that the 
results, and thus the usefulness, may vary by context. In our study, all patients had 
actively sought help, and many were, in fact, smokers. While conducting Study 1, 
we noticed that the information about smoking habits was largely missing in the 
patient records, which made it hard for us to find the exact number of smokers in 
the patient population that visited urgent primary care. Later reports have indi-
cated that physicians often fail to document information about smoking habits 
in patient records [103]. We telephoned all the otherwise eligible patients to find 
out whether they smoked prior to including them in the study. Of the 250 patients 
we telephoned, 198 (79%) confirmed they were current or former smokers. This 
number indicated that smoking was common in middle-aged patients visiting 
urgent primary care in the Tyresö-Haninge-Nynäshamn area for RTIs. We knew that 
the prevalence of smokers in the actual catchment area was high. Additionally, 
Haninge and Nynäshamn had relatively many blue-collar workers and a high sick-
leave frequency [104-106], which also may have contributed to the pattern of fre-
quent health-care seeking. Finally, as smoking may increase a person’s desire for 
antibiotics when they have a RTI [107], we were not surprised to see many smokers 
seeking a doctor’s appointment. 
6.3.1.3 The usefulness of our screening method
For three main reasons, we consider the method for detecting undiagnosed COPD 
described in Paper I a complement to other screening methods in the symptomatic 
public.
1. The approach is feasible. That is, it can easily be adapted to a real-life con-
text in which patients with airway symptoms actively seek medical care. As 
the time available in primary urgent care does not allow further investigations 
on the spot, the GP’s central action to reduce underdiagnosis is to ensure the 
patient is referred to a follow-up visit at which further investigations will be 
planned. Simplified methods for assessment of lung function, such as FEV1/
FEV6 tests at PHCCs increase efficiency in screening for COPD in risk groups 
[108, 109]. 
2. The method may be particularly useful in populations with a high prevalence 
of smoking. It is noteworthy that different surroundings and contexts may affect 
smokers’ care-seeking patterns. Thus, conclusions drawn from research results 
may also differ by context. For instance, Sweden’s sick-leave regulations, com-
bined with highly accessible primary urgent care, may have affected the results 
of Study 1.
3. The method seems more usable than public screenings for COPD, as the 
amount of time and effort required to arrange screenings is not trivial. The 
positive (61%) and negative (81%) predictive values of our model, which used 
three variables (age, smoking status, and smoking intensity) to detect COPD 
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in patients with an acute RTI were relatively high. In other words, in our study 
the probability of COPD in patients with RTI who were over 55 years old and 
had smoked more than 20 pack years was 61%. Additionally, we would falsely 
suspect that 11% of the patients had COPD and would thus refer them unnec-
essarily to spirometry. However, contact with health care professionals and a 
spirometry test would not be in vain, as it might increase patients’ awareness of 
COPD and motivate even those who did not yet have the disease to quit smok-
ing. A possible explanation for the characteristics of our model may be that the 
multiple regression analysis was influenced by the presence of random factors 
that are typical for small-sample studies. Assessment of the health economic 
consequences of our method could be an interesting topic for future research.
6.3.2 About the diagnostic criteria for COPD 
The diagnoses of COPD in Papers I and III were solely based on a fixed spirome-
try cut-off of FEV1/FVC < 0.7 as outlined in GOLD. There is always a risk of some 
misclassifications, particularly among the oldest patients, when a fixed FEV1/FVC 
is used instead of lower limit of normal (LLN) for FEV1/FVC, as the latter is adjusted 
for age and for the reference system for the population in question [110]. However, 
in Study 1, the lung function values were evenly distributed across all ages. More-
over, the mean age was 55 years, and only a few patients were 70-75 years. Thus, 
the risk of misclassifications due to fixed FEV1/FVC was reduced in this study. As 
the prevalence of COPD found in Study 1 was based on spirometry results only, the 
“true” prevalence of COPD in the study population may have been somewhat lower. 
Today, clinicians are instructed to base the diagnosis of COPD on a consistent, pro-
fessional assessment of a combination of typical patient history, clinical findings, 
and lung function measures. One of the main purposes of basing the diagnosis 
on broader information is to make it easier to discriminate between patients with 
asthma and those with COPD. 
6.4  PAPER II: REASONS FOR POOR GUIDELINE ADHERENCE AND GPs’  
  PERSPECTIVES ON THEIR WORK WITH COPD PATIENTS 
6.4.1 Getting in contact with patients with COPD
One major way that people who have or might have COPD meet a physician is 
through urgent visits (usually 10-15 minutes) prompted by acutely worse symp-
toms, which usually means the patient is exacerbating. The limited time available 
is used to provide immediate treatment for urgent airway problems. Often, the 
patient and the GP are unfamiliar with each other, which may further increase the 
risk that the GP will omit to discuss COPD or plan for a follow-up. 
  Another major way is through planned visits (usually 20-30 minutes long). 
These visits are typically annual or other regular check-ups or follow-ups for medi-
cal issues in a patient with a COPD diagnosis. Such patients may present with mild 
airway symptoms that are not obvious to the GP and not bothersome enough for 
the patient to bring up at the consultation. In fact, many patients with or at risk of 
COPD do not have ongoing, troubling symptoms when they see their GPs. Instead, 
they come to see the doctor for a reason other than COPD. They bring up many 
different problems and issues, which leads to the process of deprioritizing COPD at 
the consultation. 
  As the portal to interprofessional COPD care, GPs play a crucial role in 
identifying symptoms and signs of the disease, discussing COPD, and diagnosing 
it. Annual checkups should be planned for patients with multimorbidity, and these 
consultations should be long enough so that the different diseases or diagnoses 
can be thoroughly covered via a dialogue and medical assessment. Without a vigi-
lant GP, there will be neither diagnosis nor further COPD care.
6.4.2 GPs’ and patients personal views on COPD
Paper II discusses the reasons for poor GP adherence to guidelines and for depri-
oritizing COPD in consultations. GPs brought up factors related to clinical findings, 
organizational models, and holistic views of patients. Unlike their colleagues in 
northern Sweden [111], the Stockholm GPs did not mention lack of competence as 
a reason for deprioritizing COPD or as a reason for the gap between guidelines and 
practice. In Paper II, I found the descriptions about the patients and doctors’ levels 
of motivations for care, their personal views on COPD as a disease, and their diffi-
culty bringing up the sensitive issue of smoking to be the most interesting features 
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of the results. The GPs in Study 2 mentioned that they did not have high expecta-
tions of their patients’ capacity to change behavior and did not always trust their 
own capacity to influence the patient to change behavior. GPs may regard manag-
ing COPD like trying to swim against a stream; i.e., as not worth the trouble, given 
the small gains [112]. For instance, GPs sometimes choose not to bring up smoking 
in their discussions with patients because they do not expect the patient to be able 
to quit smoking [113]. On the other hand, if the patient presents with smoking-re-
lated symptoms, the GPs are more likely to actively support the patient’s efforts to 
quit [114].  
6.4.3 Multimorbidity
The GPs clearly confirmed the findings of previous research that the disease-ori-
ented approach in the current single-disease guidelines has often led them to 
question whether the guidelines can be applied to patients with multimorbidity 
[115]. No evidence-based guidelines for the management of patients with multi-
morbidity currently exist, despite obvious need. Thus, an international initiative to 
work on this topic is underway [116], and some steps have already been taken in 
the United Kingdom and the Netherland [117, 118]. Because of their expertise in 
treating patients who have multimorbidity GPs should play a central role in writing 
such guidelines. 
6.4.4 GPs’ reflections on their professional identity
Consistently aiming to be vigilant and observant is an essential part of working 
successfully as a GP. In addition to the theoretical model, Study 2 gave rise to 
general reasoning about the core features of family medicine and the work and 
identity of GPs. GPs’ identity and medical specialty is not only associated with 
competence and expertise, but also with the way GPs’ everyday work is done. Paper 
II describes how being a specialist in managing patients with unselected medical 
conditions and patients with multimorbidity, together with a holistic view of people, 
give rise to a firm sense of GPs’ identity. These descriptions parallel some of Matti 
Klockars’ (a Finland-based professor in family medicine) reflections about “the 
identity of a GP” [10]. Among the concepts Klockars believes are central to GPs’ 
identity are their ability to live with uncertainty, the value they place on continuity 
of care, their ability to think epidemiologically, their ability to coordinate their own 
work, and their patient-centered rather than disease-oriented approach. A study 
of young doctors in Finland showed that GPs saw themselves as humanists with a 
social orientation, health promoters, and care providers, whereas hospital doctors 
considered themselves to be people who cure, who engage in science, and who 
conduct research [119]. 
  Professional identity is built through a person’s internal sense of belonging 
to a group and through outsiders’ perceptions and descriptions of the group. Today, 
GPs’ sense of belonging and others’ perceptions of GPs may be threatened by es-
calating workloads that lead to a decrease in GPs’ sense of autonomy [120]. Stress 
is also a problem. GPs are not invulnerable to the emotional demands of their work 
[121] and may experience ethical stress due to new diagnostic and therapeutic 
options that seem endless [10, 120]. These problems could make it challenging to 
build a strong identity “from within.” A network of collegial support and dialogue via 
CME adjusted to GPs’ needs is more crucial than ever.
6.4.5 Methodological considerations concerning grounded theory
GTM is a qualitative research method that offers a systematic and interpretive way 
to move from data to a theory that has the potential to explain, interpret, and ulti-
mately guide clinical practice. The core idea of GTM is that it can be more relevant 
to develop a theory in direct response to immediate problems than to start with 
a hypothesis or a pre-existing theory and test it [76]. The GTM we used in Study 2 
was mainly inspired by the constructivist views of Charmaz [70]. It involves actively 
acknowledging that the researcher as not an objective observer and analyst, but an 
individual taking part in the data collection phase and constructing the theoretical 
model. As the constant parallel data collection and comparative analysis advanc-
es, researchers must continuously examine and strive to be aware of how their 
values and preconceptions may affect their interpretation. 
  A number of methodological considerations are particularly relevant to 
GTM:
- Variation in the study population. The heterogeneity of the study population is 
crucial to collecting “rich data” in qualitative studies. The theoretical sampling 
in Study 2 contributed to good variation in the study population. 
- Interview quality. The interviewer (HS), who was familiar with interview tech-
niques from previous work, followed a semi-structured interview guide. After 
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each interview, the research group evaluated its work, documenting what hap-
pened in the interview and their future plans in memos. Interview guides were 
revised as the study proceeded.
- Results. Thorough analysis by the research group contributed to grounded 
and structured results. The results were original; i.e., new information was 
uncovered, as the area was previously unstudied. The results were relevant 
and useful, because they were further implemented in a new CME intervention 
(Study 3). They were trustworthy, because they were credible (i.e., the final the-
oretical product was actually “grounded” in the data) and consistent.  This cred-
ibility and consistency were enhanced by the interviewer’s familiarity with the 
topic and settings, the thorough methods used to collect and analyze data, and 
linking the conceptual categories and empirical data. However, in Paper II we 
could have further clarified the evidence of credibility by describing the whole 
process of developing the theory more explicitly and in greater detail. Specifi-
cally, we could have described the flow of theoretical sampling more thoroughly. 
The results were resonant and reliable; their correspondence to participants’ 
experiences was verified in the last two focus group interviews. As previously 
noted, the researchers were careful to evaluate their objectivity during the en-
tire analytical process. However, as is generally true of GTM studies, the results 
presented in Paper II cannot be generalized outside of the sample, but they may 
be transferrable to similar contexts.  
6.4.6 Using the new information to create an educational intervention 
The theoretical model presented in Paper II (Figure 6) was based on GPs’ descrip-
tions about the process that occurs when COPD is deprioritized at a patient-doctor 
consultation. However, the data uncovered many strategies that were the opposite 
of the “negative path” (deprioritization), revealing a corresponding “positive path” 
(prioritization). The positive path (Figure 9) described the factors GPs thought lay 
behind successful COPD care. The positive path was incorporated into the PRIMAIR 
educational intervention in Study 3. Each intended learning outcome was to be 
achieved by basing learning activities on examples from the positive path, using 
mainly didactic pedagogics in the TL arm and case method learning and discus-
sions in the CM arm.  
Citations from the data illustrate how GPs’ nonjudgmental views on smoking and 
neutral attitudes towards COPD can lead to prioritization: 
”I’m always nagging about smoking. I see it as a fringe benefit.”  
( F, ”Anti-smoking doctor”)
”I have seen so many other types of patients who live miserable lives, either self-in-
flicted or because of other things … I mean, I’m not here to be the police.”  
(I, ”Equating all diseases”)
Some GPs described how using a holistic consultation technique instead of fo-
cusing on each diagnosis separately helped them grasp both the patient’s main 
agenda and how seemingly different medical issues interacted to make up a whole: 
Figure 9.   A model summarizing the process of prioritization of the positive path COPD at a pa-
tient-doctor meeting.
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”I need to know how the patient is feeling. It gives me loads of information. I give 
feedback, summarize, make open questions and confirm while the patient tells me 
things. So I’m familiar with my patients, and many problems get solved, because I 
have the information about the patient.”  
(J2, ”Seeing associations,” ”Keeping up continuity”)
When GPs felt that the patients were highly motivated to receive COPD care, the 
discussion was likely to move toward active or proactive measures. They thought 
that patients who experience worrying symptoms are likely to be motivated to take 
in information about the disease and accept treatment suggestions. 
”But when they start to feel symptoms they get worried. Really worried, so that they 
don’t come at all because they neglect the concern, or else they come to have a 
severe disease excluded. Cancer and COPD.” 
(D3, ”Patient worrying about severe disease”)
6.4.7 What might patients think are the reasons for COPD deprioritization? 
Studies about patients’ perspectives on the reasons for deprioritized discussions 
about COPD are scarce. A cross-sectional, descriptive study from Canada in which 
the researchers used a validated questionnaire in 364 patients indicated that a 
satisfactory patient-physician relationship and continuity correlated most strongly 
with good care for chronic conditions (diabetes, hypertension, or COPD). Moreover, 
in the patients’ view, interdisciplinary care and technical quality of care contributed 
only modestly to good care [122]. On the other hand, other studies have indicated 
that continuity of care from an interprofessional team that also provides education 
in self-management improves patients’ motivation to receive care and adhere to 
medications [53, 122, 123]. Patients have reported that a nonjudgmental attitude 
toward smoking is essential for decreasing shame and increasing the patient’s 
motivation to receive treatment for COPD [124, 125]. Patients with COPD also call 
for more psychological support than what is currently typical after an acute exac-
erbation, as feelings of loss, hopelessness, and uncertainty are common [126]. A 
follow-up visit with a GP shortly after an acute exacerbation could thus provide the 
opportunity to schedule an appointment with a COPD nurse for intensified psycho-
logical support via motivational interviews about smoking cessation. 
6.5  PAPERS III AND IV: EFFECTS OF CONTINUING MEDICAL EDUCATION  
  FOR GPs
 
The overall results described in Paper IV show that CME about COPD generally 
leads to learning although evaluating the effects of a single CME intervention for 
GPs is challenging. Both pedagogical methods—CM and TL—led to improvements 
in total scores on the questionnaire. However, neither of the methods was superior 
to the other. Additionally, the positive effects were only modest and thus left room 
for substantial improvement. 
  Perhaps unexpectedly, GPs at PHCCs with nurse-led asthma/COPD clinics 
did not know more about COPD or have better COPD management skills than GPs 
at PHCCs without such clinics. This may be a result of GPs handing over parts of 
their responsibilities to asthma/COPD nurses. An alarming finding was that GPs 
working in deprived areas in Stockholm were at particular risk of delivering insuffi-
cient COPD care.
6.5.1 Level of knowledge about COPD before and after the CME intervention
The results described in Paper IV revealed that even after the CME interventions, 
strong areas of knowledge remained strong and weak areas weak among the 
participating GPs. Neither of the CME methods led to significant improvements in 
managing COPD in patients with multi- and comorbidities, managing acute exacer-
bation under time pressure, managing patients who lack motivation to quit smok-
ing, or handling patients whose focus during the consultation is something other 
than COPD. Thus, these typical real-life conditions and problems encountered by 
GPs remain difficult to overcome with two short sessions of CME regardless of 
whether lectures or case methods are used. 
6.5.1.1 Smoking cessation 
At baseline and 12 months, GPs best levels of knowledge and adherence to recom-
mendations were observed in the area of smoking cessation support. Traditional 
lectures led to further improvements in the results regarding smoking cessation 
support for motivated patients. The overall good results were not surprising, as 
the effects of quitting smoking (i.e., lower risk of COPD and slower disease pro-
gression [69, 127]) are well understood by clinicians. The baseline results showed 
that most GPs employed behavioral strategies to promote smoking cessation, and 
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every other GP combined them with pharmacological approaches [79]. This result 
may also reflect increasing access to primary care nurses competent in motiva-
tional interviewing. However, it is important to point out the gap between what GPs 
know about smoking and what they do. Earlier research has shown that doctors 
rarely take active measures to help patients quit smoking [128]. The preliminary 
results of analyses of PRIMAIR data on patients with GOLD 2-3 COPD indicate that 
approximately 60% of the current or former smokers (n=382) had not been offered 
smoking cessation support, and 80% had not been given such support by their GPs 
or nurses (Sandelowsky, in manuscript). GPs need to understand their important 
role in motivating patients to quit smoking. This role needs to be given continuous 
attention in CME situations.
6.5.1.2 Spirometry
GPs seemed to want to employ spirometry as recommended in guidelines, which 
is in line with the overall improved awareness of spirometry in diagnosing airway 
diseases [53]. However, spirometry interpretation skills remained suboptimal at 
baseline in all the studied groups, although CM led to small, yet significant im-
provements. The “hands-on,” participatory learning activities in CM, such as study-
ing and discussing spirometry curves, may have been effective. Conclusions should 
be drawn with caution, however, because only one of the 13 questions measured 
spirometry interpretation skills, and guides for spirometry interpretation were not 
allowed. Interestingly, the poor spirometry interpretation results were not echoed 
in the findings of Study 2. The GPs interviewed in Study 2 did not even mention 
problems with spirometry interpretation as a reason for deprioritizing COPD. GPs’ 
unrealistic assessments of their own spirometry interpretation skills may explain 
the discordance, or it may have been the result of the inability to use interpretation 
guides when responding to the questionnaire. The presence of an asthma/COPD 
clinic seemed to be associated with low scores in spirometry interpretation. One 
possible explanation is that GPs have transferred this responsibility to specialized 
asthma/COPD nurses, resulting in stagnation in the GPs’ own skills in spirometry. 
6.5.1.3 Acute exacerbations
The results on managing follow-up visits after acute exacerbations were satis-
factory (regarding the proper time and contents of the visit). However, both pre- 
and post-CME, the treatment of an ongoing exacerbation was among the items 
that showed the worst results. The baseline data showed a negative association 
between GPs’ level of knowledge about these topics and the presence of asthma/
COPD clinics, again, possibly indicating that GPs hand over their responsibilities 
to asthma/COPD nurses. The choices of antibiotics seemed largely satisfactory, 
but oral steroids were underused to treat exacerbations [79], which has also been 
shown in a previous Swedish study [129]. The CME had no effects on GPs’ level of 
knowledge about the topics involving acute exacerbations.
6.5.1.4 Management of stable COPD 
CME did not affect GPs’ skills in managing pharmacological maintenance therapy, 
which were insufficient both pre- and post-CME. Baseline results indicated that 
GPs overprescribed inhaled corticosteroids [79], which is in line with previous 
research [130]. Lack of familiarity with recommendations and uncertainties about 
correct diagnosis (i.e. whether patient has asthma or COPD) may lie behind this 
finding. GPs underused pulmonary rehabilitation (PR) despite the high accessibility 
of PR in Swedish primary care [131]. GPs’ inadequate knowledge of the importance 
of PR in treatment, which can both cause and be caused by insufficient experience 
and lack of routines, have previously been mentioned as explanations of the low 
rates of referral to PR [132]. 
6.5.1.5 Multimorbidity 
GPs generally paid insufficient attention to COPD during patient consultations, 
except consultations for acute exacerbations. They struggled to handle COPD when 
patients with multimorbidity had several health issues to discuss in a limited time. 
The patient’s agenda, which clearly did not always include COPD, often led the GP 
to omit COPD, although the GP was aware of the diagnosis. This finding supports 
the results of Study 2. 
  Many patients do not recognize the importance of COPD and its long-term 
implications [133]. It is thus crucial that GPs bring up COPD in discussions with 
patients and use their expert knowledge about the disease to give the patient a 
picture of how the often extrapulmonary features are connected and interact with 
each other. Additionally, the absence of guidelines for assessing and managing 
patients with multimorbidity contributes to poor COPD management [134] and 
insufficient interprofessional cooperation. Both patients and clinicians may thus 
perceive health care pathways as fragmented and unsatisfactory [135]. 
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6.5.2 Bridging the implementation gap: translational research 
Failure to translate research into practice and policy is one of the most consistent 
findings from clinical and health services research [136]. Despite significant finan-
cial investments in biomedical, clinical, and public health research; undergraduate 
training and CME; and projects to improve quality and patient safety, healthcare 
systems and professionals still fail to ensure that effective and cost-effective 
programs, services, and drugs get to those who need them [136]. The discipline that 
focuses on this subject is called implementation science, or preferably, transla-
tional research. The two main types of translational research are “T1 research,” 
the translation of basic biomedical research into clinical science and knowledge, 
and “T2 research,” the translation of this new clinical science and knowledge into 
actions in practice and thus improved health [137]. T2 researchers argue that 
“evidence-based medicine should be complemented by evidence-based implemen-
tation” [138]. Researchers planning the framework for translational activities, such 
as CME, and the subsequent analysis of these activities should answer five key 
questions: What knowledge should be transferred, and to whom, by whom, how, and 
with what effect should it be transferred? [139]. In this thesis, I have followed the 
seven essential steps needed for a well-conducted translational research project 
defined by the Knowledge Translation Theories Group at University of Ottawa [140]: 
1. Identify care gaps and the need for change (Paper I).
2. Identify barriers to the consistent use of guidelines (Paper II).
3. Review evidence from previous implementation interventions on similar topics  
 (Papers III-IV).
4. Tailor or develop the intervention (Papers III-IV).
5. Implement the intervention (Paper IV).
6. Evaluate the process of implementation (Paper IV, except cost analysis).
7. Evaluate outcomes of the intervention (Paper IV).
To complete steps 3-7, the PRIMAIR researchers will continue to study patient 
outcomes.
6.5.3 Challenges in using CME for knowledge translation
6.5.3.1 The effectiveness of CME interventions  
Evidence on the most effective and feasible types of CME is still incomplete [136]. 
Compared to educational and pedagogical research about undergraduate learning, 
CME research is a fairly young discipline. However, the number of studies on the ef-
fectiveness of CME is increasing because of a growing focus on cost-effectiveness 
in health care. The Effective Practice and Organisation of Care Group (EPOC) states 
that systematic reviews provide the best evidence about the effectiveness of 
CME interventions [141, 142]. Based on EPOC’s statement, Grimshaw et al. (2012) 
concluded that systematic reviews should be used to discuss and develop CME, as 
studies about individual CME interventions may be misleading because of bias in 
their conduct or random variations in their findings [135]. Individual CME interven-
tions do not generally result in large absolute effect sizes. Most clustered trials are 
powered to detect absolute improvements of 10% to 20%. Under these circum-
stances, it is not surprising that different types of interventions have had similar 
effect sizes. Table 8 summarizes EPOC’s list of professional behavior change strat-
egies and their effectiveness at the time we created the PRIMAIR intervention.
Table 8.   Summary of The Cochrane Effective Practice and Organisation of Care (EPOC) group’s 
review of professional behavior change strategies and effectiveness, 2011.
Intervention Effect size Dispersion
Printed educational materials 4.3% Range −8.0% to +9.6% 
Educational meetings 6.0% IR1, +1.8% to 15.3%
Educational outreach 4.8% IR, +3.0% to + 6.5%
Local opinion leaders 12.0% IR, +6.0% to +14.5%
Audit and feedback 5.0% IR, +3% to +11%
Computerized reminders 4.2% IR, +0.8% to +18.8%
Tailored interventions  Pooled odds ratio of 1.52 95% CI2, 1.27 to 1.82, p < 0.001 
1 IR = Interquartile range   2 CI = confidence interval
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6.5.3.2 Is repetition the foundation of learning?
There is no solid evidence that either multifaceted educational interventions (in-
terventions with multiple components) or repeated exposure to CME on the same 
topic (reminders) guarantee the translation of knowledge to practice [136]. Under-
graduate training, specialist training, and CME constitute a continuum of profes-
sional development that takes place over many years. This continuum should be 
kept in mind when interpreting the results of isolated interventions such as those 
listed in Table 8 because one CME intervention might be based on, boosted by, 
or lead to another intervention. Each CME intervention can affect an individual 
participant’s interest in the topic in different ways. In summary, the effects sizes of 
participating in multiple interventions over time are probably bigger in real life than 
Table 8 might indicate.  
6.5.3.3 What characterizes an effective CME for GPs?
GPs’ work is characterized by first-line management of unselected health prob-
lems and holistic assessments. GPs also manage multiple diseases rather than 
diseases of a specific organ system or age group. A CME intervention that enhanc-
es GPs’ learning experience should be tailored to primary care settings and should 
have patient-centered content that reflects the nature of primary care practice 
[143]. Research shows that multiple educational activities are more effective than 
single activities [63, 144]. Nevertheless, GPs seem to want to attend traditional, 
didactic CME sessions. Moreover, they seem to prefer CME via group sessions to 
CME on their own (e.g., on-line courses) [64]. In a recent Stockholm-based study, 
Ingemansson et al. described the core elements of how GPs learn and transfer 
information from guidelines to their practice. GPs use interactive (peer) contex-
tualized dialogues. They gain confidence that they are providing high quality care 
through own or others’ experiences, and they use guidelines that are easy to access 
and adapt to the decision-making process [145]. Additionally, a study from the 
United Kingdom found that in a situation of clinical uncertainty, contact with hos-
pital doctors and observation of hospital practice was as likely as using guidelines 
to bring about changes in GPs’ practice [146]. 
6.5.3.4 Mandatory or optional CME for GPs?
Although the managers of PHCCs in Stockholm are obligated to provide GPs with 
the CME the GPs consider necessary, GPs are not required to participate in CME. 
The current reimbursement system does not encourage managers to promote CME 
for GPs. Educational meetings at the workplace are well-received by professionals 
[147]. Although feasible and relatively inexpensive to carry out in primary care set-
tings (their main cost is related to the release time for GPs) [136], educational meet-
ings at the workplace are nevertheless deprioritized. Consequently, the number of 
GPs participating in CME activities is decreasing [12]. GPs indicate that time con-
straints, staffing problems, and increasingly heavy workloads are the main reasons 
for deprioritizing of CME [88]. Because CME for GPs is so deprioritized in Sweden 
today, The Swedish Medical Association (physicians’ union) has recently announced 
that they aim to actively lobby for mandatory CME for all physicians [148].
6.5.3.5 Implementing and researching CME is a complex task   
Whereas undergraduate educators are often professional pedagogues, CME edu-
cators are often professional clinicians with limited pedagogical training. They may 
thus be less well-equipped than professional pedagogues to face the potential pit-
falls of implementing and assessing CME. Although the amount of CME research 
is growing, many current CME activities may still be based on beliefs rather than 
evidence about the likely effectiveness of different approaches [138]. 
  We faced a number of methodological challenges in designing and con-
ducting Study 3, which may have biased the results: 
  Identifying barriers to guideline adherence before designing CME activities. 
Researchers studying guideline implementation agree that gathering information 
about the likely barriers to and facilitators of implementation increases the chanc-
es of creating a successful CME intervention. Barriers are preferably identified at 
the planning and designing stage of a CME intervention. Methods of identifying 
barriers and facilitators can be qualitative (e.g., individual interviews, focus groups, 
and participant observation) or quantitative (surveys) [149]. We used the results 
of Study 2 and other previous research to identify GPs’ barriers to COPD guideline 
adherence, and we believe this method was sufficient. 
  Research based on real-life context is never precise. It is usually not pos-
sible to implement a CME intervention in a clean-cut, objective, and “scientific” 
manner because of the biases that characterize real-life contexts. In Study 3, the 
CME sessions were led by different teachers with varying teaching styles, which led 
to heterogeneity in the interventions. Each CME session also varied in the compo-
sition of the participants and in contexts. It was thus impossible to use a “one size 
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fits all” approach.
  Assessing the effects of CME: the GP questionnaire. The biggest challenge in 
the CME implementation process is often to create a good assessment tool. We no-
ticed a pattern of contradictions and dilemmas in method of assessment we chose. 
In the GP questionnaire, the assessment method (multiple choice questions and 
short, free-text answers) was appropriate for assessing learning at SOLO levels 1 
to 3. That is, it aligned with the level of intended learning outcomes that were facil-
itated by teaching and learning activities in both intervention arms. The question-
naire was designed this way for practical reasons (to keep it short) and because we 
hoped to find out whether the higher-level learning activities in the CM arm would 
result in better lower-level (SOLO 1-3) learning than TL. However, this choice meant 
that the questionnaire was not directly designed to capture the higher-order think-
ing or the professional approach required to achieve intended learning outcomes 
at SOLO levels 4 to 5 [150]. Thus, we do not know for sure whether or not the GPs 
achieved these higher levels of learning.
  Using “Miller’s pyramid of competence,” Wass et al. have argued that to 
be reliable and valid, assessments must use multiple methods. The demands 
on assessment methods increase when one moves from assessing the level of 
knowledge at the base of the pyramid (when the student “Knows”) to the following 
two levels (“Knows how” and “Shows how”) and finally to the apex (“Does”) [151]. 
However, we mixed multiple choice with open questions to achieve a well-con-
structed question stem that forced participants to show not only their level of lex-
ical knowledge (“Knows”), but also their capacity to identify and solve problems by 
assessing the whole situation described in the case vignettes (“Knows how”). Thus, 
the GP questionnaire revealed theoretical knowledge and self-reported, preferred 
actions but did not measure the two highest levels of knowledge in Miller’s pyra-
mid. In other words, we were unable to assess whether the GPs’ behaviors changed 
in practice. Self-reports are usually subject to bias and thus not recommended 
for use as the sole measure of guideline adherence [152]. PRIMAIR therefore also 
includes an assessment of patient outcomes. This analysis is currently underway.
  Constructing questions requires particular care. The overall goal is to de-
sign questions that will be answered correctly by those who know the answer and 
incorrectly by those who do not. Questions on a test and items on a questionnaire  
should be characterized by the following qualities [153, 154]:
- Cognitive complexity, which permits various levels of learning to be tested; e.g.,  
 by testing different levels of Biggs’ SOLO taxonomy [81].
- Content quality, because the test questions will permit participants to demon- 
 strate their knowledge.
- Meaningfulness, which makes test questions worth participants’ time and   
 helps students recognize and understand their value.
- Language appropriateness, so that the question is clear and coherent to both  
 the teachers and the participants.
- Transferability and generalizability, so that successful performance on the test  
 actual knowledge achieved.
- Fairness, so that performance is scored in the same way for everyone.
- Reliability, so that answers to test questions measure what participants know.
We improved the quality of the questions and thus even parts of the reliability of 
the questionnaire via a “think-aloud” pilot test with a group of GPs who would not 
later participate in the intervention. 
  Placement of questions on the questionnaire matters, too: easy questions 
should be placed in the beginning so responders will gain confidence. Short-answer 
questions and sensitive questions (e.g., about attitudes and demographic) should 
be placed last [153]. We could not follow this advice strictly, as the questionnaire 
consisted of five separate case vignettes, and each vignette required a range of easy 
to short-answer questions. The way questions are worded and responses are scaled 
is also important, especially if the questions are about attitudes or involve approx-
imations [155]. We chose not to include any questions that obviously addressed 
attitudes and personal views in order to reduce the risk of social desirability bias; 
i.e., people’s tendency to respond in a way that they think is socially preferable [155]. 
Finally, the modestly positive results of Study 3 led me to reflect on the overall 
design of the GP questionnaire: 
- Could the test have been too hard?  The research group thoroughly discussed  
whether the chosen questions were aligned with the intended learning out-
comes and learning activities (Biggs’ constructive alignment [80]). We aimed 
to include the issues that would best reflect the participants’ competence in 
managing COPD (evidence-based practice, correct diagnoses, recommended 
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treatments, holistic views of multimorbidity, team work, ethical practice, and 
communication skills).
- Were the scoring requirements too strict? The scoring criteria also followed the 
principles of constructive alignment and were discussed by the research group. 
However, the intended learning outcomes were not presented to the partic-
ipants prior to the CME, which may have negatively affected learning, as the 
participants could not see what they were expected to learn. 
- Was the scaling of scores (0-2 points per question) too narrow? A test with a 
mix of easy and difficult questions and a scale (scores) with more than three 
steps would have helped discriminate between the participants and changes in 
scores over time. 
6.6  GPs’ KEY ROLE IN MANAGING PATIENTS WITH COPD
6.6.1 The stigma of COPD complicates the management of the disease
COPD is a chronic condition that often has a major impact on patients’ lives. 
Receiving the diagnosis can be a life-changing experience, as can living with the 
disease every day, going through exacerbations, approaching the end-of-life stage, 
and contacting and communicating with care providers [47]. In the Merriam-Web-
ster dictionary, stigma is defined as “a scar left by a hot iron, a mark of shame or 
discredit and an identifying mark or characteristic.” The stigma of COPD has been 
the topic of increasing discussion in the scientific literature, as it seems to de-
crease GPs’ ability to deliver evidence-based COPD care. According to a systematic 
review (2017), patients with COPD are commonly stigmatized. The stigma is associ-
ated with psychosocial, behavioral, physical, and treatment- and employment-re-
lated outcomes [156]. The stigma can be affected, negatively or positively, by the 
people the patient encounters, including the GP. 
6.6.2 The circle of COPD management
Figure 10 illustrates my thoughts about how different actors are involved in and in-
teract in the management of COPD. The stigma of COPD is created and kept alive via 
actors throughout the whole circle, including the public, health care professionals 
and their managers, and patients. Each actor is also a member of the public, and in-
dividuals can play more than one role simultaneously (e.g., a GP can also be a mem-
ber of the research community or a patient can also be a politician or a health care 
manager), so complicated interactions may occur. Depending on the actions taken, 
one of two kinds of circles can be initiated: a negative, “vicious” circle of underman-
agement of COPD or a positive, “health promoting” circle of COPD management.
Figure 10.   The circle of COPD management.
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6.6.3 Actions leading to the vicious circle of undermanagement of COPD
Lack of knowledge and negative views about COPD in the public lead to depriori-
tization of COPD in the minds of the public, politicians, researchers, CME leaders, 
public health care mangers, and finally, in professionals in both secondary and 
primary health care. In the end, patients are not only left without optimal care, but 
also get multiple signals that COPD is not important, which maintains and feeds 
the stigma of COPD. Thus, with stigma as its engine, the vicious circle is complete 
and continues to run. 
  The public demands high quality care and easily accessible health care 
services. Additionally, the public has a generally negative view of smoking and 
demands that tobacco use is regulated in public places [157]. Thus, most elect-
ed politicians share these views, and execute the desired policies via new laws. 
However, the anti-tobacco actions of policymakers do not always mean that they 
supply sufficient resources to manage smoking-related diseases, prevent tobacco 
use, or carry out smoking-related research projects [158]. Instead, the focus of the 
tasks of public health care lies elsewhere. The public’s demand for readily acces-
sible healthcare is highly prioritized in Sweden today. Officials in the health care 
bureaucracy carry out political decisions by creating reimbursement schemes that 
encourage prompt and numerous patient visits to primary care. Long-term work 
to prevent people from smoking or help the quit, interprofessional management of 
patients with multimorbidity, and professional development and CME come sec-
ond. The poor COPD detection rate described in Paper I and the insufficient man-
agement of COPD described in Papers II to IV are natural consequences of these 
schemes. This leads to insufficient patient education and insufficient support for 
self-management, which in turn means patients are poorly prepared to handle 
their disease, especially at times of exacerbation. Poorly prepared patients experi-
encing exacerbation contribute to the public’s need for easy-to-access urgent care, 
continuing the vicious circle of undermanagement of COPD. 
6.6.4 GPs role in breaking the vicious circle 
GPs’ core professional skills are particularly important to reducing the stigma of 
COPD, and ultimately, to delivering optimal COPD care. Key competencies include 
a high level of knowledge about and good skills in managing COPD, chronic condi-
tions, and multimorbidity. GPs should use a holistic consultation technique as their 
main tool for gaining and giving information about the impact of COPD in patients’ 
lives and assessing their health. Public understanding of COPD is still relatively low, 
and false and frightening stories flourish in people’s minds and in the daily press. 
GPs thus have a crucial role to play as educators and leaders. Through evidence, 
they can improve the level of the general knowledge about COPD and help shape 
public opinion. Just as in the fight against smoking, it is urgent for GPs to shoulder 
their responsibility as trustworthy and professional clinicians, inspiring educators 
and mentors, consistent authorities and leaders, and strong opinion makers [159]. 
  Because of GPs’ key role in COPD care, GPs’ role as patient educators de-
serves further attention. Neutral yet supportive and evidence-based information 
delivered by health care professionals increases both patients’ and professionals’ 
adherence to guidelines [53, 160]. Even successful smoking cessation, which is 
possibly the most difficult and stigma-burdened part of COPD care, is easier to 
achieve with professional patient education and support [161]. 
  At present, most patients are first offered structured patient education, in-
cluding action plans for exacerbations, when their lung function has declined below 
50% of predicted (i.e., GOLD stages 3 and 4) and they have repeated exacerbations, 
hospital admissions, significant every-day symptoms, and reductions in health-re-
lated quality of life [162, 163]. However, research indicates that many patients have 
had exacerbations before entering GOLD stages 3 and 4 [129, 164, 165]. 
  The preliminary results of a questionnaire to randomly selected COPD 
patients (n=567) at the PHCCs participating in PRIMAIR indicate that patients 
in stage 2 have a greater need for information about COPD than those in stage 3. 
Moreover, they more often considered themselves not capable of self-managing 
an exacerbation (p<0.05-0.005). Many doctors think of patient education as a task 
of COPD nurses, but patients with a great need for information deem contact with 
their GP more important than contact with a COPD nurse (Sandelowsky, in man-
uscript). For this reason, and because many patients already experience exacer-
bations in stage 2, I reason that GPs should begin educating patients, preferably 
in cooperation with an asthma/COPD nurse, earlier than is common today. GPs 
are competent patient educators when they provide adequate yet respectful and 
supportive information about the natural course of COPD, gather rich information 
about the patient’s agenda, subsequently assess the situation together with the 
patient and the patient’s family. Supporting patients in their lifetime journey with 
COPD may help reduce the fear, guilt, shame, and stigma associated with COPD 
and help patients cope with the disease.
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6.6.5 The six factors behind successful management of chronic conditions 
  by GPs
GPs’ actions in managing chronic conditions are typically the result of a combina-
tion of pragmatism and evidence-based medicine. This approach distinguishes 
GPs from other physicians, as it is based on the person-centered and holistic view 
that is central to competent general practice. It develops gradually over many 
years in the profession. However, Swedish health care authorities emphasize that 
“evidence based practice” is an important goal of primary care. Quantitative and 
qualitative studies have identified six factors crucial to providing evidence-based 
general practice [166, 167]:
1. Taking multimorbidity into account when constructing guidelines. GPs rarely 
consider single disease guidelines useful in primary care patients, as these 
patients often have multiple diseases. It is therefore essential to involve GPs 
in the design of clinical recommendations and care programs for patients with 
multimorbidity.
2. Having access to digital clinical support guidelines that are easy to access, 
updated, concise, easy to use, and adjusted for primary care. Guidelines are 
necessary, as GPs may find it difficult to find and select useful information from 
among the large volume of research evidence and then finding time to read, 
appraise, and understand this information.
3. Taking part in CME on a regular basis. GPs’ participation in CME activities needs 
to be encouraged and rewarded by PHCC managers. CME needs to be effective, 
as well as adjusted to, interesting for, and feasible to carry out at primary care 
practices. 
4. Following one’s own clinical results by regularly monitoring desired measures, 
such as diagnoses, prescriptions, and actions.  
5. Daring to change old habits. Sometimes GPs show considerable skepticism 
toward new recommendations, which radically slows down the implementa-
tion process. This can be counteracted by visualizing, discussing, and com-
paring the GPs’ own results and any deviations from the guidelines, preferably 
through collegial dialogues.
6. Prioritizing quality over money. A long-term commitment to evidence-based 
practice by PHCC managers is crucially important. Step-by-step changes work 
better than trying to make the changes all at once. For example, focusing on 
care processes for specific diagnosis groups, one at a time, helps to achieve 
value for the money spent.
6.7  IT’S ABOUT TIME 
6.7.1 Time is money: more and faster
A recurrent theme found in the results and discussions of this thesis is time. Like 
most people in modern society, GPs are constantly reminded about time. Terms like 
“efficiency” and “production plan” that were coined during the industrial age have 
been adapted in most Western health care systems, and the emphasis on maxi-
mizing the use of time has only grown in recent decades. Stockholm’s primary care 
reimbursement model resembles a marketplace where each action has a differ-
ent price tag. Some tags have a large price on them (e.g., patient visits) and bring 
more money to the PHCC. Some tags have no price (e.g., contacts with patients by 
telephone or letter) or a negative figure (e.g., referrals to external investigations or 
attending CME) and are consequently deprioritized. 
  In recent years, our society has become globalized and increasingly “knowl-
edge-based.” Quickly and easily available information can simplify and shorten 
decision-making procedures. Indeed, never before have GPs been able to access 
information as quickly as they can today. However, new problems arise when 
people take it for granted that quick access to information always equals quick 
decisions. Additionally, the idea that we can be more efficient than ever before 
has spilled over into health care, but the reality of health care as experienced by 
GPs does not bear this out. Instead, as activities that carry price tags with zeros or 
negative numbers are deprioritized, care suffers. GPs are robbed of the time they 
need to process new information and manage tasks that require concentration and 
intellectual engagement, such as evaluating and caring for patients with mult-
morbidity. If this suboptimal care situation continues or even increases, costs to 
society, patients, and their families will escalate.
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6.7.2 The lack of time
Demands for immediate care put person-centered care at risk [168, 169] by short-
ening consultations; consultations that are too short can leave both patients and 
physicians unsatisfied. GPs consider time constraints and lack of resources, such 
as sufficient staffing, the main reasons for inadequate quality of care [146, 170]. 
A meta-synthesis of qualitative studies parallels these concerns, concluding that 
the key to patient safety lies in face-to-face communication between patients and 
professionals, collegial dialogues, and interprofessional cooperation and commu-
nication [171]. 
  Given that GPs in Sweden experience high levels of stress despite relatively 
long consultations times (24 minutes, the longest in an international comparison 
of 67 countries) [12, 172], the problem may be even greater in other Western coun-
tries. However, there are differences between countries regarding typical diagno-
ses and the severity of health conditions treated primary care, which makes such 
comparisons tricky. 
6.7.3 It’s all about time 
It is time to realize how changes in society and medicine in recent decades have 
radically changed the nature of primary care and family medicine [173]. Com-
plex decision-making happens regularly each day in primary care, and this deci-
sion-making takes time. Inevitably, when GPs feel that they lack time, it perpetu-
ates the gap between theory and practice.
  It takes years to become a competent GP. The necessary CME that helps 
GPs maintain sufficient competence also takes time. 
  In other words, GPs deal with time-consuming but life-saving actions. Giving 
them the time and resources they need for professional development will pay off. 
Neglecting the time pressure that currently casts a shadow across GPs’ work con-
ditions jeopardizes the quality of primary care and recruitment of new GPs, making 
these topics serious and growing concerns in the future. 
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COPD is a potentially life-threatening, chronic disease. Its progress can be slowed 
relatively easily and inexpensively by smoking cessation. GPs play a crucial role 
in bringing about optimal management of patients at risk of COPD and those with 
COPD. However, to deliver acceptable care to patients with COPD, GPs need more 
time and resources than they have today.
  In Study 1 (Paper I), we concluded that patients 40 years or older who have 
smoked more than 20 pack years and who have any type of respiratory infection 
may have underlying COPD. It is thus crucial for GPs to identify this high-risk group 
and offer them spirometry testing to detect COPD early. This may motivate those 
patients to quit smoking. 
  In Study 2 (Paper II), we discovered that COPD is deprioritized during 
patient-doctor consultations in primary care and identified several factors associ-
ated with time constraints and multimorbidity that are involved in the deprioritiza-
tion process. We suggest that GPs actively apply a holistic consultation approach 
and extend consultation times for patients with multimorbidity. In addition, we call 
for better documentation of COPD-related issues and better local routines, partic-
ularly for planning of disease monitoring. 
  In Study 3 (Paper IV), we concluded that GPs’ level of knowledge and skills 
about COPD are generally low. Furthermore, it is difficult to improve these skills, 
at least through short continuing medical education sessions that use either case 
method learning or traditional lectures. In fact, the use of any single continuing 
medical education method in short sessions should be questioned as a strategy 
for improving management of patients with multimorbidity.
7.  CONCLUSIONS
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The results of this thesis may contribute to a constructive dialogue between the 
public, policy makers, and medical professionals, as a strong primary health care 
system and sufficient financing are prerequisites for high quality and cost-effec-
tive management of COPD and other chronic diseases [2, 174]. Additionally, the 
thesis sheds light on the unused potential of GPs to use their power as trusted 
medical advisors to enhance patients’ understanding of COPD and influence them 
to take the necessary steps to improve their condition; most importantly, to quit 
smoking. The results also illuminate the professional identity and unique contribu-
tions of GPs, which will hopefully boost their professional pride at a moment when 
time and other pressures are placing a particular strain on many GPs. 
  Most of all, I hope the thesis inspires GPs to nurture and improve their ex-
pertise in managing patients with multimorbidity. They should strive to participate 
in writing the guidelines for assessing multimorbidity, as current clinical guidelines 
for single diseases tend to promote polypharmacy and offer no guidance on how 
to prioritize recommendations in these patients [175]. Another important goal is 
improving medical students’ understanding of the impact of COPD in patients with 
multimorbidity, as medical students still receive a predominantly hospital-based 
education oriented toward single diseases.
  In the near future, together with the PRIMAIR research group, I will continue 
evaluating patient outcomes. These studies will primarily provide new information 
about symptoms, treatments, and levels of self-management skills before and 
after the CME intervention. The outcomes of the patient studies will also help us 
measure whether GPs achieved the more advanced intended learning outcomes 
described in Paper III. A clear difference between patient outcomes and GP out-
comes would indicate that the GP questionnaire (described in Papers III and IV) 
needs improvement. 
  Designing and conducting a study about the effectiveness of accumulat-
ed CME activities and knowledge translation over several years of a GP’s career 
would be interesting but so time-demanding that it is probably not feasible. A more 
feasible and also useful future study could investigate whether easy-to-access 
guidelines about COPD are helpful to GPs. 
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9.1  BAKGRUND
Allmänläkaren är primärvårdens specialistläkare och allmänmedicin primärvår-
dens medicinska specialitet. Allmänläkarens arbete har genomgått stora föränd-
ringar under de senaste decennierna. I takt med att slutenvårdsplatserna har 
minskat i Sverige och befolkningen blivit äldre och därmed också alltmer multi-
sjuka, handlägger allmänläkarna och övrig primärvårdspersonal fler patienter med 
allt svårare kroniska sjukdomar. En sådan sjukdom är kroniskt obstruktiv lungsjuk-
dom (KOL). Det  är en inflammatorisk luftrörs-/lungsjukdom i vilken samsjuklighet 
med andra kroniska sjukdomar är vanligt. I Sverige beräknas 400 000–700 000 
personer ha KOL. Cirka hälften av dessa personer beräknas vara odiagnostiserade.  
Diagnosen misstänks främst bland rökande patienter som uppvisar kliniska fynd 
förenliga med KOL, och den bekräftas med spirometri, som vid KOL påvisar en icke-
reversibel obstruktivitet i de nedre luftvägarna. Tobaksrökning är den viktigaste 
orsaken till KOL, och rökstopp har en central roll i behandling och bromsande av 
fortsatt progress av sjukdomen. 
  Då majoriteten av patienterna med KOL upptäcks, behandlas och kontrol-
leras i primärvården är det av största vikt att diagnostiken och kvaliteten på vården 
där är optimal för att minska mortalitet och morbiditet i denna patientgrupp. Att 
upptäcka KOL i tidigt stadium är viktigt för att motivera patienten till rökstopp 
och för att symtomlindrande behandling ska kunna sättas in. Då kan progress 
av sjukdomen bromsas och kostnader för samhället minskas. Allmänläkaren är 
i en nyckelposition för att upptäcka patienter med KOL tidigt och se till att de får 
optimal vård. Allmänläkarens kompetens att göra professionella bedömningar med 
helhetssyn över patientens individuella förutsättningar är viktig för patientens 
prognos. 
  Sedan flera år finns internationella och nationella riktlinjer och rekommen-
dationer som beskriver diagnostik, uppföljning och behandling av KOL. Tidigare 
svenska studier har påvisat att det finns stora brister i hur både primärvården och 
den specialiserade vården följer riktlinjerna. Det finns ett stort behov att studera 
orsaker till detta, både hos allmänläkare som yrkesgrupp och primärvården som 
organisation. 
  För allmänläkarnas kompetens krävs effektiva utbildningsprogram anpas-
sade för primärvårdens behov. Det är vanligt att allmänläkare försöker tillfreds-
ställa sitt behov av bred och kontinuerlig allmänmedicinsk fortbildning genom 
att delta i ett par timmar långa utbildningar inom en rad medicinska områden. 
På sådana utbildningar är en traditionell föreläsningsbaserad pedagogik vanligt 
förekommande, med eller utan inslag av deltagaraktiverande moment. Traditio-
nella föreläsningar baseras på att en lärare, som är expert i ämnet, förmedlar 
kunskap till deltagarna. Casemetodik är en deltagaraktiverande utbildningsmetod 
med professionsspecifika perspektiv. Deltagaren ställs inför realistiska problem, 
beskrivna i ett praktikfall eller “case”, i vilket professionen (i vårt fall allmänläkaren) 
är huvudpersonen i caset. Frågeställningen i ett case bygger på att det inte finns 
något korrekt svar (däremot kan det finnas felaktiga eller i varje fall orealistiska 
lösningar), vilket betyder att lärarens roll är att främja deltagarnas diskussion 
och egna tänkande, snarare än att vara den som sitter inne med och presenterar 
kunskapen. Deltagarens egen aktivitet före och under casediskussionen är avgö-
rande för lärandet. Casemetodiken har tidigare visat goda resultat i samband med 
fortbildning av allmänläkare i Stockholm, men inga studier om casemetodikens 
effekter i KOL-fortbildningar har genomförts tidigare i Sverige. 
9.2  MÅLSÄTTNING
Den övergripande målsättningen med denna avhandling var att beskriva under-
diagnostik av KOL som ett exempel på en konsekvens till otillräcklig följsamhet 
till riktlinjerna för KOL (Vad är problemet?), orsaker till allmänläkares bristande 
följsamhet till riktlinjerna för KOL (Varför finns problemet?) och utvärdera effekt av 
fortbildning på allmänläkares kunskaper i KOL (Kan vi göra något åt problemet?).  
9.3  MATERIAL OCH METOD
Avhandlingen består av fyra delstudier. I delstudie 1 (artikel I) identifierades preva-
lens och svårighetsgrad av tidigare oupptäckt KOL bland patienter i åldern 40-75 
år som var eller hade varit rökare och som hade fått diagnos akut luftvägsinfektion 
av en allmänläkare vid Handens Närakutmottagning eller Brandbergens vårdcen-
tral.Patienterna genomförde en spirometriundersökning 5-6 veckor efter läkarbe-
söket och karakteristika för patienter som visade sig ha tidigare odiagnostiserad 
KOL beskrevs. Studien genomfördes under 2005-2006.
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I delstudie 2 (artikel II) identifierades hinder för tillämpning av riktlinjer och vård-
program. De omständigheter som styr om allmänläkarna tar upp och diskuterar 
KOL med patienter undersöktes genom en kvalitativ studie enligt Grounded Theory 
Methodology (GTM) med intervjuer av allmänläkare. Allmänläkare (n=59) vid olika 
vårdcentraler i Stockholms län deltog antingen i fokusgrupps- eller individuella 
intervjuer under 2012-2013.
  Delstudie 3 (artiklar III och IV) är en klusterrandomiserad kontrollerad 
studie (PRIMAIR) i vilken effekten av en för allmänläkare riktad fortbildningsin-
tervention i KOL implementerades och utvärderades. Interventionens syfte var att 
öka allmänläkares kunskap om evidensbaserad KOL-vård i primärvården för att 
förbättra handläggning av deras patienter. Studien genomfördes 2014-2017. Den 
hade två interventionsarmar: casemetodik jämfördes med traditionell fortbild-
ning. Dessutom jämfördes bägge studiearmarna med en referensgrupp i vilken 
deltagarna inte fick fortbildning. Utfallen mättes både på  de allmänläkare som 
fick fortbildning (kunskap, kompetens) och på deras patienter (livskvalitet, sym-
tomupplevelse, rökstopp). Frågeformulär användes för datainhämtning bland både 
läkare och patienter. Artikel III är en så kallad protokollartikel i vilket PRIMAIR-stu-
diens upplägg och metodik redovisas i detalj. Artikel IV beskriver genomförandet av 
PRIMAIR-studien bland allmänläkarna och dess resultat. Resultat på patientnivån 
ingår inte i denna avhandling. 
9.4  RESULTAT
Delstudie 1 (artikel I) visade att av rökande (eller tidigare rökande), medelålders 
eller äldre patienter utan känd lungsjukdom, som sökt akut i primärvården på 
grund av en luftvägsinfektion, hade 27 % KOL (95 % CI ±7 %). Av dem hade 44,7 
% KOL i GOLD stadium 1 (mild KOL, FEV1≥80 % av förväntat), 52,6 % stadium 2 
(medelsvår KOL, 50 %≤FEV1<80 % av förväntat), 2,6 % stadium 3 (svår KOL, 30 
%≤FEV1<50 % av förväntat) och 0 % i stadium 4 (mycket svår KOL, FEV1 <30 % av 
förväntat). Vi fann ett signifikant samband mellan KOL och ålder ≥55 (OR = 10,9 [95 
% CI 3,8-30,1]) och mellan KOL och rökningsintensitet (paketår > 20) (OR = 3,2 [95 
% CI 1,2-8,5]). Kön, aktuell rökningsstatus och typ av luftvägsinfektionsdiagnos vid 
akutbesöket hade inte signifikant samband med förekomst av KOL. 
  Delstudie 2 (artikel II) beskrev hur tidspress ledde till nedprioritering av 
KOL i ett patient-läkarmöte. Vid oplanerade (akuta) besök ledde den knappa kon-
sultationstiden till att allmänläkarens fokus enbart låg i att lösa det mest akuta 
problemet och att fortsatt planering av KOL-vård uteblev. Vid planerade besök (t 
ex årskontroller) blev KOL nedprioriterad bland en rad andra hälsoproblem och 
diagnoser, då de allra flesta patienter med KOL hade flera andra samtidiga sjukdo-
mar. Orsakerna till att allmänläkarna nedprioriterade KOL var att läkaren inte var 
medveten om KOL, inte blev orolig för KOL på grund av de kliniska fynd som just då 
fanns hos patienten, hade en negativ inställning till KOL som sjukdom och rökare i 
största allmänhet, använde sig av diagnosorienterad konsultationsteknik (istället 
för helhetssyn), uppfattade att patienten inte var motiverad för KOL-vård inklusive 
rökstopp och att det saknades fungerande rutiner för KOL-vård på vårdcentralen.
Delstudie 3 (artiklar III och IV) visade att både casemetodik och traditionella före-
läsningar som fortbildningspedagogik ledde till små men signifikanta förbättringar 
i allmänläkarens resultat i ett kunskapstest om KOL (totalpoäng för casemetodik 
10,34 vs 11,44; och för traditionella föreläsningar 10,21 vs 10,91; p<0,05, max total-
poäng 26 p.) Det fanns få skillnader mellan de två fortbildningsmetoderna. Kon-
trollgruppens totalpoäng förändrades inte över tid och var signifikant lägre efter 12 
månader än båda de andra gruppernas totalpoäng (casemetodik och traditionella 
föreläsningar). Kunskaperna om tobaksavvänjning var generellt höga, medan 
kunskaperna om spirometritolkning, interprofessionell samverkan och multi- och 
samsjuklighet var låga, både före och efter fortbildningsinterventionen. 
9.5  SLUTSATSER
I denna avhandling har KOL presenterats som ett exempel på en vanlig kronisk 
sjukdom där majoriteten av patienterna tas om hand av primärvården. KOL är en 
potentiellt livshotande, kronisk sjukdom, vars progress kan stoppas genom att sluta 
röka. Allmänläkares kompetens och möjligheter att handläggapatienter med KOL är 
avgörande för att ge dem som lider av denna vanliga, dyra och dödliga folksjukdom 
en optimal vård. Emellertid behöver allmänläkare i Sverige mer tid och resurser för 
att i sitt vardagliga, kliniska arbete kunna upprätthålla sin kompetens och fullgöra 
sin uppgift att både upptäcka, behandla och följa upp patienter med KOL. 
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